================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(MARK ONE)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED JULY 31, 1998
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM _________ TO_________.
Commission File Number 0-17754
CONSILIUM, INC.
---------------
(Exact name of registrant as specified in its charter)
Delaware 94-2523965
-------------- ------------
(State or other jurisdiction of (IRS Employer Identification No.)
incorporation or organization)
485 Clyde Avenue, Mountain View, California 94043
- - ------------------------------------------- --------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (650) 691-6100
--------------
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed under Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
X
Yes _________ No _________
Indicate the number of shares outstanding of each of the issuer's classes of
common stock as of September 3, 1998:
Common Stock, $0.01 par value 8,637,352
- ----------------------------- ---------
Class Number of Shares
<PAGE>
CONSILIUM, INC.
INDEX
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements:
Condensed Consolidated Balance Sheets
July 31, 1998 and October 31, 1997
Condensed Consolidated Statements of Operations
Three and nine months ended July 31, 1998 and 1997
Condensed Consolidated Statements of Cash Flows
Nine months ended July 31, 1998 and 1997
Notes to Condensed Consolidated Financial Statements
Item 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risks
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
Item 2. Changes in Securities
Item 3. Defaults Upon Senior Securities
Item 4. Submission of Matters to a Vote of Security Holders
Item 5. Other Information
Item 6. Exhibits and Reports on Form 8-K
Signatures
<PAGE>
CONSILIUM, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
<TABLE>
<CAPTION>
July 31, October 31,
1998 1997
----------- -----------
(unaudited)
<S> <C> <C>
ASSETS
Current assets:
Cash and cash equivalents....................... $6,665 $7,865
Accounts receivable, net........................ 9,299 11,014
Other current assets............................ 608 590
----------- -----------
Total current assets.................. 16,572 19,469
Property and equipment, net....................... 2,630 4,312
Software development costs, net................... 1,991 2,688
Goodwill, net..................................... 2,116 3,092
Other assets...................................... 364 406
----------- -----------
TOTAL ASSETS.......................... $23,673 $29,967
=========== ===========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Note payable/Line of credit..................... $917 $3,051
Accounts payable................................ 2,612 6,587
Accrued liabilities............................. 3,676 3,799
Accrued acquisition costs....................... 300 1,662
Deferred revenue................................ 5,378 6,437
----------- -----------
Total current liabilities............. 12,883 21,536
Note payable...................................... 1,833 --
Accrued lease obligation.......................... 157 --
Deferred revenue.................................. 467 --
----------- -----------
Total liabilities..................... 15,340 21,536
Stockholders' equity.............................. 8,333 8,431
----------- -----------
TOTAL LIABILITIES AND
STOCKHOLDERS' EQUITY.................. $23,673 $29,967
=========== ===========
</TABLE>
The accompanying notes are an integral part of these condensed consolidated
financial statements.
<PAGE>
CONSILIUM, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(IN THOUSANDS, EXCEPT PER SHARE DATA)
(UNAUDITED)
<TABLE>
<CAPTION>
Three Months Ended Nine Months Ended
--------------------- ---------------------
July 31, July 31, July 31, July 31,
1998 1997 1998 1997
---------- ---------- ---------- ----------
<S> <C> <C> <C> <C>
REVENUES:
Product......................... $1,945 $4,420 $6,282 $11,234
Services........................ 5,742 6,405 17,922 18,826
Development..................... -- 84 -- 514
---------- ---------- ---------- ----------
Total revenues............ 7,687 10,909 24,204 30,574
---------- ---------- ---------- ----------
COST OF REVENUES:
Product......................... 228 778 1,078 2,483
Services........................ 2,347 3,593 7,980 11,475
Development..................... -- -- -- 369
---------- ---------- ---------- ----------
Total cost of revenues.... 2,575 4,371 9,058 14,327
---------- ---------- ---------- ----------
GROSS MARGIN......................... 5,112 6,538 15,146 16,247
---------- ---------- ---------- ----------
OPERATING EXPENSES:
Research and development........ 2,048 3,015 6,344 9,250
Selling and marketing........... 2,135 3,483 7,474 10,094
General and administrative...... 710 1,006 2,167 2,809
---------- ---------- ---------- ----------
Total operating expenses.. 4,893 7,504 15,985 22,153
---------- ---------- ---------- ----------
Income (loss) from operations........ 219 (966) (839) (5,906)
Interest income...................... 74 34 166 98
Interest expense..................... (56) (102) (239) (173)
Gain on sale of business............. -- -- 550 --
---------- ---------- ---------- ----------
INCOME (LOSS) BEFORE
INCOME TAX PROVISION........... 237 (1,034) (362) (5,981)
PROVISION FOR INCOME TAXES........... 33 147 175 262
---------- ---------- ---------- ----------
NET INCOME (LOSS).................... 204 (1,181) (537) (6,243)
PREFERRED STOCK DIVIDENDS............ (225) -- (838) --
---------- ---------- ---------- ----------
NET LOSS ATTRIBUTABLE TO
COMMON STOCK.................... ($21) ($1,181) ($1,375) ($6,243)
========== ========== ========== ==========
NET LOSS PER COMMON SHARE
Basic and diluted............... ($0.00) ($0.15) ($0.16) ($0.78)
WEIGHTED AVERAGE COMMON SHARES AND
EQUIVALENTS
Basic and diluted............... 8,486 8,018 8,503 7,974
</TABLE>
The accompanying notes are an integral part of these condensed consolidated
financial statements.
<PAGE>
CONSILIUM, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
<TABLE>
<CAPTION>
Nine Months Ended
------------------------
July 31, July 31,
1998 1997
----------- -----------
<S> <C> <C>
Cash flows from operating activities:
Net loss...................................... ($537) ($6,243)
Adjustments to reconcile net loss to
net cash used for operating activities:
Depreciation and amortization............... 2,638 2,694
Gain on sale of business.................... (550) --
Change in assets and liabilities:
Accounts receivable...................... 1,715 (5,221)
Other assets............................. (85) (213)
Accounts payable......................... (3,445) 143
Deferred revenue......................... 328 2,870
Other liabilities and accrued expenses... (612) 2,628
----------- -----------
Net cash used for operating activities. (548) (3,342)
----------- -----------
Cash flows from investing activities:
Capital expenditures.......................... (242) (912)
Capitalized software development costs........ (990) (525)
Sales of short-term investments............... -- 1,000
Cash paid for acquisition of FAST............. (300) --
Cash received from sale of HCP................ 1,350 --
----------- -----------
Net cash used for investing activities. (182) (437)
----------- -----------
Cash flows from financing activities:
Proceeds from note payable/line of credit..... 2,750 3,051
Principal payments line of credit/note payable (3,051) (1,792)
Issuance costs of preferred stock............. (105) --
Proceeds from issuance of common stock and
exercise of options........................ 228 288
----------- -----------
Net cash provided by (used for)
financing activities................. (178) 1,547
----------- -----------
Effect of exchange rate changes on cash............ (292) (388)
----------- -----------
Net decrease in cash and cash equivalents.......... (1,200) (2,620)
Cash and cash equivalents at beginning of period... 7,865 8,094
----------- -----------
Cash and cash equivalents at end of period......... $6,665 $5,474
=========== ===========
</TABLE>
The accompanying notes are an integral part of these condensed consolidated
financial statements.
<PAGE>
CONSILIUM, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. INTERIM FINANCIAL DATA
The interim condensed consolidated financial statements of Consilium, Inc. and
its subsidiaries ("the Company") are unaudited but reflect, in the opinion of
management, all normal recurring adjustments necessary to present fairly the
financial information set forth therein. These interim condensed consolidated
financial statements should be read in conjunction with the audited financial
statements and notes thereto included in the Company's annual report on Form
10-K for the year ended October 31, 1997. The Company believes the results of
operations for the three and nine months ended July 31, 1998 and the cash
flows for the nine months ended July 31, 1998 are subject to fluctuation and
are not necessarily indicative of results of operations and cash flows for any
future period.
2. NET LOSS PER SHARE
Effective November 1, 1997, the Company adopted SFAS No. 128, "Earnings Per
Share." All prior-period earnings per share data presented was restated to
conform with SFAS No. 128. SFAS No. 128 requires companies to compute net
income (loss) per share under two different methods, basic and diluted, and to
disclose the methodology used for the calculation.
Basic and diluted earnings per common share were computed by dividing
net loss after deduction of preferred stock dividends by the weighted average
number of shares of common stock outstanding during the period. Potentially
dilutive securities of 2,257,462 and 1,733,070 were not included in the
computation of diluted earnings per common share because to do so would have
been antidilutive for the three quarters ended July 31, 1998 and 1997,
respectively.
3. LINE OF CREDIT / NOTE PAYABLE
As of April 30, 1998, the Company had $3,051,000 outstanding under the Line of
Credit Agreement dated April 1, 1997 with its existing bank. On July 24, 1998,
the Company entered into a new banking arrangement and paid off all amounts
due under the above mentioned Line of Credit Agreement. Under this new
facility, the Company can borrow up to $6,500,000, including a $2,750,000
three year term loan (the "Term Loan Agreement"), and an additional line of
credit (the "Revolving Facility Agreement") of up to $3,750,000 based on
eligible accounts receivable. The term loan agreement is secured by
substantially all of the Company's assets, bears interest at 1.0% above the
prime rate per annum (9.5% at July 31, 1998) and expires on July 24, 2001.
The revolving facility agreement is secured by substantially all of the
Company's assets, bears interest at 0.5% above the prime rate per annum (9.0%
at July 31, 1998) and expires on July 24, 1999. At July 31, 1998, $2,750,000
was outstanding under the Term Loan Agreement and no borrowings were
outstanding under the Revolving Facility Agreement. The Term Loan and
Revolving Facility Agreements require the Company to maintain certain
financial covenants. The Company is in compliance with all financial
covenants.
4. NEW ACCOUNTING PRONOUNCEMENTS
In the first quarter of fiscal 1998, the Company adopted the
provisions of SFAS No. 129, "Disclosure of information about Capital
Structure," which requires companies to disclose certain information about
their capital structure. The adoption of SFAS No. 129 had no impact on the
Company's financial statements.
In April 1998, the American Institute of Certified Public Accountants
issued Statement of Position (SOP) 98-1, "Accounting for the Costs of Computer
Software Developed or Obtained for Internal Use." SOP 98-1 provides guidance
regarding the determination of whether computer software is internal-use
software, the capitalization of costs incurred for computer software developed
or obtained for internal use and accounting for the proceeds of computer
software originally developed or obtained for internal use and then
subsequently sold to the public. The Company has not yet determined the
effect, if any, of adopting SOP 98-1, which will be effective for the Company
in fiscal 2000.
In June 1998, the Financial Accounting Standards Board issued SFAS No.
133, "Accounting for Derivative Instruments and Hedging Activities." The
Statement establishes accounting and reporting standards requiring that every
derivative instrument (including certain derivative instruments embedded in
other contracts) be recorded in the balance sheet as either an asset or
liability measured at its fair value. SFAS No. 133 is effective for fiscal
years beginning after June 15, 1999. Management believes the adoption of SFAS
No. 133 will have no effect on the Company's financial statements.
5. SALE OF HEALTH CARE AND PROCESS BUSINESS UNIT
In February 1998, the Company sold certain assets of its Healthcare
Products and Process Industries Group that focused on the FlowStream product
line (the "Healthcare Group"), pursuant to an Asset Purchase Agreement dated
February 19, 1998 (the "Asset Purchase Agreement") by and among Base Ten
FlowStream, Inc. (the "Buyer"), Base Ten Systems, Inc. (the "Parent" and
together with the Buyer, "Base Ten") and the Company, for consideration
consisting of $1,500,000 in cash, 20% of all annual revenues in excess of
$3,200,000 recognized by Base Ten from the licensing of the FlowStream product
line during the 1998 and 1999 calendar years, and assumption by Base Ten of
substantially all of the Healthcare Group's liabilities on a going-forward
basis, with some specific obligations being retained by the Company. Pursuant
to the Asset Purchase Agreement, Base Ten assumed certain liabilities as of
the acquisition date, purchased fixed assets with a net book value of
approximately $500,000 and assumed the Company's rights under certain
contracts with customers and other third parties relating to the FlowStream
product line, except certain patents used within the Company by both the
Healthcare Group and the Semiconductor and Electronics Business Group. With
regards to these patents, the Company granted to Base Ten a worldwide
royalty-free, non-transferable (except with substantially all of the assets of
the FlowStream Business) license, for the lives of the patents, without the
right to sublicense, to the exclusive use of such patents for developing,
producing, manufacturing and selling manufacturing execution systems limited
to the field of healthcare products (pharmaceutical, medical device and
biotechnology) and chemical industries. In addition, the Company agreed not
to compete in the business of developing, producing, manufacturing and selling
manufacturing execution systems under the trademark of "FlowStream" for
healthcare products and chemical industries for three years. Also pursuant to
the Asset Purchase Agreement, the Company agreed to indemnify Base Ten for up
to $1,500,000 for certain representations and warranties relating to
intellectual property and up to an unlimited amount for certain post-closing
covenants, any excluded obligations (as defined in the Asset Purchase
Agreement) and any tax losses (as defined in the Asset Purchase Agreement).
<PAGE>
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
The discussion in this report contains in addition to historical information,
forward-looking statements which reflect the Company's current views with
respect to future events and financial performance. These forward-looking
statements are subject to certain risks and uncertainties, including those
discussed in this report. The Company's actual results could differ
significantly from the results discussed in the forward-looking statements.
In this report the words "anticipates," "believes," "expects," "intends,"
"may," "future" and similar expressions identify forward-looking statements.
Readers are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. The following discussion
should be read in conjunction with the Consolidated Financial Statements and
Notes thereto.
OVERVIEW
In fiscal 1996, the Company began offering systems integration services to the
semiconductor manufacturing industry. In an effort to grow its systems
integration business, in July 1996, the Company acquired the Taiwan operations
of SDI, a privately-held Washington corporation specializing in the
development of factory automation products and systems integration services
for the semiconductor industry. The Company purchased two existing
semiconductor plant automation contracts, certain tangible and intangible
assets and assumed certain liabilities of SDI. The acquisition was accounted
for as a purchase and, accordingly, the results of the Taiwan operations of
SDI since the date of acquisition have been recorded in the Company's
consolidated financial statements.
In August 1997, the Company again expanded its systems integration business by
acquiring certain assets of FAST, a Singapore corporation specializing in
semiconductor manufacturing automation with operations both in Singapore and
Taiwan. The Company purchased two existing semiconductor factory automation
contracts, certain tangible and intangible assets and assumed certain
liabilities of FAST. The acquisition was accounted for as a purchase and
accordingly, the results of FAST from the date of acquisition forward have
been recorded in the Company's consolidated financial statements. See
"LIQUIDITY AND CAPITAL RESOURCES."
In February 1998, the Company sold certain assets associated with its
FlowStream product line to Base Ten and agreed not to compete in the
FlowStream Business for three years.
RESULTS OF OPERATIONS
REVENUES. Total revenues for the third quarter of fiscal 1998 decreased
30% to $7,687,000, compared with $10,909,000 in the third quarter of fiscal
1997. Revenues for the first nine months of fiscal 1998 decreased 21% to
$24,204,000, compared with $30,574,000 in the same period of fiscal 1997. For
the three and nine months ended July 31, 1998, the decreases in total revenues
over the same periods of the previous fiscal year were primarily due to the
sale of the Health Care and Process business unit, a lower level of WorkStream
DFS T product revenues, systems integration services revenues and development
revenues, partially offset by a higher level of consulting revenues from its
Semiconductor and Electronics business unit.
Percentage of total revenues for the three and nine months ended July
31, 1998 and 1997 by geographic region were as follows (in thousands):
<TABLE>
<CAPTION>
Three Months Ended Nine Months Ended
------------------- -------------------
July 31, July 31, July 31, July 31,
1998 1997 1998 1997
--------- --------- --------- ---------
<S> <C> <C> <C> <C>
North America................... $3,214 $5,954 $12,167 $14,573
Percentage of total revenues.. 42% 55% 50% 48%
Europe.......................... 1,701 2,306 5,311 5,789
Percentage of total revenues.. 22% 21% 22% 19%
Asia/Pacific.................... 2,772 2,649 6,726 10,212
Percentage of total revenues.. 36% 24% 28% 33%
</TABLE>
The proportional decrease in sales to North America for the three and nine
months ended July 31, 1998 were due to the sale of the Health Care and Process
business unit and lower level of WorkStream product license and maintenance
revenues in the North America region. The decrease in sales to Europe for the
three and nine months ended July 31, 1998 were due to the sale of the Health
Care and Process business unit. The proportional increases in sales to
Asia/Pacific for the three months ended July 31, 1998 was due to the mix of a
slight increase in product license sales to Asia/Pacific combined with a
decrease in total revenue during the period. For the nine months ended July
31, 1998, the proportional decrease in sales to Asia/Pacific was primarily due
to lower WorkStream license revenue and lower systems integration services
revenues in the Asia/Pacific region as a result of the completion of existing
projects, slowdown in the building of new semiconductor fabrications, as well
as currency fluctuations in Asia.
Percentage of total revenues for the three and six months ended July 31,
1998 and 1997 by business unit were as follows (in thousands):
<TABLE>
<CAPTION>
Three Months Ended Nine Months Ended
------------------- -------------------
July 31, July 31, July 31, July 31,
1998 1997 1998 1997
--------- --------- --------- ---------
<S> <C> <C> <C> <C>
Semiconductor and Electronics
Business Unit
(WorkStream DFS(TM))........... $7,687 $8,875 $22,206 $26,355
Percentage of total revenues.. 100% 81% 92% 86%
Healthcare Products and Process
Industries Business Unit
(FlowStream(R))................ $0 $2,034 $1,998 $4,219
Percentage of total revenues.. 0% 19% 8% 14%
</TABLE>
The Company's Semiconductor and Electronics Business Unit markets and
sells WorkStream DFS products to manufacturers who produce their products in
discrete lots or batches, particularly those in the semiconductor and
electronics industries. The Company's Healthcare Products and Process
Industries Business Unit marketed and sold FlowStream products to regulated or
complex industries that employ batch process manufacturing, particularly those
in the healthcare products (pharmaceutical, medical devices and
biotechnology), chemical and other process industries until the Company sold
substantially all the assets and liabilities of the division on February 19,
1998.
Product Revenues. Product revenues for the three and nine months ended
July 31, 1998 decreased 56% and 44% over the same periods of the previous
fiscal year. The decreases were primarily due to lower product revenue levels
from the Company's WorkStream DFS and FlowStream product lines during the
periods, as described below.
Product revenues attributable to products in the Company's WorkStream
DFS product line decreased 41% to $1,945,000 during the three months ended
July 31, 1998, as compared with $3,307,000 for the same period in fiscal 1997.
For the nine months ended July 31, 1998, product revenues from the WorkStream
DFS product line decreased 45% to $5,340,000, as compared with $9,763,000 in
the previous fiscal year. The period over period decreases were primarily due
to the continued slowdown in the semiconductor industry, the Asian currency
issues and fluctuations in timing of new orders for WorkStreamr products from
new semiconductor fabrications.
Product revenues attributable to FlowStream for the three and nine
months ended July 31, 1998 were zero and $910,000, as compared to $1,113,000
and $1,471,000 for the same periods in fiscal 1997. The decreases were
attributable to the sale of the Health Care and Process business unit in the
second quarter of fiscal 1998.
Services Revenues. Services revenues for the three months ended July 31,
1998 decreased 10% to $5,742,000, compared with $6,405,000 for the same period
of fiscal 1997. For the nine months ended July 31, 1998, services revenues
decreased 5% to $17,922,000, compared with $18,826,000 for the same period of
fiscal 1997. Services revenues are primarily from annual software maintenance
fees, systems integration services relating to the WorkStream DFST product
line, specialized programming services, resident and application consulting
services and customer training. The decreases in services revenues for the
three and nine months ended July 31, 1998 were primarily due to the sale of
the Health Care and Process business unit, and a decrease in systems
integration services revenues, partially offset by an increase in consulting
services revenues from the Company's WorkStream product line. Services
revenues normally are subject to fluctuations primarily due to the timing of
new contracts and the completion of existing projects.
Development Revenues. The Company has no development revenues for
the three and nine months ended July 31, 1998, compared with $84,000 and
$514,000 for the same periods of fiscal 1997. Development revenues include
work associated with porting agreements and development contract work for
third parties. Under these contracts and agreements, the Company earns
development and porting revenues, with participating third parties having the
right to license and use the software, often sooner than otherwise would have
occurred. Development revenues can vary significantly from period to period,
depending upon the number of contracts which have been entered into and the
state of completion of such projects. The decreases in development revenues
during the three and nine months ended July 31, 1998 were primarily due to the
completion of all funded development projects. Based on current internal
development resource allocations and projects planned, the Company expects
that the Company will not have any significant development revenues in fiscal
1998, although the Company may take on additional development projects in the
future if business and strategic objectives of the Company are met by such
projects.
COSTS AND EXPENSES
Cost of Product Revenues. Cost of product revenues for the three months
ended July 31, 1998 decreased 71% to $228,000, compared with $778,000 for the
same period of the previous fiscal year. The absolute dollar and percentage
decreases in cost of product revenues for the three months ended July 31, 1998
were primarily due to lower product license sales and lower third party
software product costs, compared with the same period of fiscal 1997. For the
nine months ended July 31, 1998, cost of product revenues decreased 57% to
$1,078,000, compared with $2,483,000 for the same period of fiscal 1997. The
absolute dollar and percentage decreases in cost of product revenues for the
nine months ended July 31, 1998 were primarily due to lower product license
sales during the period. Cost of product revenues includes amortization of
capitalized software development costs, royalties, and purchased software
which is resold to the end customer, typically along with the Company's own
software. Depending on the mix of sales of proprietary software (and the
variance in associated third party royalties) and additional third party
software relating to specific orders, the associated costs of product revenue
can vary significantly. Product costs as a percentage of product revenues for
the three and nine months ended July 31, 1998 were 12% and 17%, respectively,
compared with 18% and 22% for the same periods of the previous year. The
decrease in cost of product revenues for the three months ended July 31, 1998
as a percentage of product revenues was attributable to lower third party
product costs and lower royalties associated with the product revenues during
the period.
Cost of Services Revenues. Cost of services revenues decreased 35% to
$2,347,000 for the three months ended July 31, 1998, compared with $3,593,000
for the same period of the previous fiscal year. For the nine months ended
July 31, 1998, cost of services revenues decreased 30% to $7,980,000, compared
with $11,475,000 for the same period of the previous fiscal year. The
decreases in absolute dollars and percentage of cost of services revenues were
primarily due to lower third party systems integration consulting costs, lower
systems integration services revenues and lower FlowStream services revenues
as a result of the sale of the Health Care and Process business unit in the
second quarter of fiscal 1998, partially offset by the hiring of additional
permanent services personnel to support the systems integration services.
Cost of services revenues was 41% and 45% of total services revenues for the
three and nine months ended July 31, 1998, respectively, compared with 56% and
61% in the comparable periods of fiscal 1997. The decrease in cost of
services revenues as a percentage of services revenues was primarily due to an
increase in systems integration projects with higher margins in fiscal 1998.
Cost of Development Revenues. Cost of development revenues decreased to zero
for the nine months ended July 31, 1998, compared with $369,000 for the same
period of the previous fiscal year. The absolute dollar decrease in cost of
development revenues for the nine months ended July 31, 1998 was primarily due
to the completion of all funded development projects in fiscal 1997.
Development costs, which may vary significantly from project to project,
include direct labor costs associated with development contracts and porting
projects as well as third party consulting expenses.
Research and Development Expenses. Research and development expenses
represented 27% and 26% of total revenues for the three and nine month periods
ended July 31, 1998, respectively, compared with 28% and 30% for the same
periods of the previous fiscal year. Research and development expenses were
$2,048,000 and $6,344,000 for the three and nine months ended July 31, 1998,
respectively, as compared to $3,015,000 and $9,250,000 for the same periods of
the previous fiscal year. The decrease in the percentage of research and
development expenses as a percentage of total revenues and the decrease in the
absolute dollar amount of research and development expenses for the three and
nine months ended July 31, 1998 were primarily due to lower overall research
and development activities as a result of the sale of the Health Care and
Process business unit coupled with the continued move of the Company's
software development group to India by subcontracting with HCL Infosystems,
and the reimbursement of research and development expenses of $324,000 under
an Advanced Technology Program (ATP) award form the National Institute of
Standards and Technology (NIST). Included in research and development
expenses are costs associated with the development of new products and the
costs of enhancing and maintaining existing products.
Software development expenditures of $168,000 and $287,000 were
capitalized for the three months ended July 31, 1998 and 1997, respectively.
The amounts represent approximately 8% and 9% of total research and
development expenditures during such periods, respectively. The absolute
dollar and percentage decreases were due to a decrease in the amount of
software development costs eligible for capitalization during the quarter
ended July 31, 1998. In accordance with SFAS No. 86, the amount of research
and development expenditures capitalized in a given time period depends upon
the amount of development work performed subsequent to the establishment of
technological feasibility for a product. Accordingly, amounts capitalized may
vary from period to period.
Selling and Marketing Expenses. Selling and marketing expenses represented 28%
and 31% of total revenues for the three and nine months ended July 31, 1998,
respectively, as compared with 32% and 33% for the same periods of fiscal
1997. The decrease in sales and marketing expenses as a percentage of total
revenues during the three and nine months ended July 31, 1998 was due to a
lower level of sales activities, partially offset by lower total revenues
during the periods. Selling and marketing expenses were $2,135,000 and
$7,474,000 for the three and nine months ended July 31, 1998, respectively,
compared with $3,483,000 and $10,094,000 for the same periods of the previous
year. The decreases in the absolute dollar amount of selling and marketing
expenses for the three and nine months ended July 31, 1998, compared with the
same periods in fiscal 1997, were primarily due to an overall decrease in
headcount and related travel expenses as a result of the sale of the Health
Care and Process business unit and the Company's efforts to control overall
operating expenses relative to revenues.
General and Administrative Expenses. General and administrative expenses
represented 9% of total revenues for the three and nine month periods ended
July 31, 1998, respectively, as compared with 9% for the same periods of the
previous fiscal year. General and administrative expenses were $710,000 and
$2,167,000 for the three and nine months ended July 31, 1998, compared to
$1,006,000 and $2,809,000 for the same periods in fiscal 1997. The decrease
in absolute dollars for the three and nine months ended July 31, 1998 was
primarily due to an overall decrease in headcount and the Company's efforts to
control operating expenses relative to revenues. General and administrative
expenses include the costs of the finance, accounting and administrative
operations of the Company.
Interest Income and Expense. Interest income was $74,000 and $166,000 for the
three and nine months ended July 31, 1998, respectively, compared to $34,000
and $98,000 for the same periods in the previous fiscal year. Higher invested
cash balances and slightly higher interest rate levels accounted for the
increase in interest income. Interest expense was $56,000 and $239,000 for
the three and nine months ended July 31, 1998, respectively, compared to
$102,000 and $173,000 for the same periods in fiscal 1997. The increase in
interest expense was primarily due to higher outstanding short term borrowings
in fiscal 1998.
Provision for Income Taxes. The income tax provision for the nine months
ended July 31, 1998 represents taxes on earnings of certain foreign
subsidiaries, which are profitable, and taxes paid in certain foreign
jurisdictions. The Company has established a 100% valuation allowance against
its deferred tax asset and reviews this allowance on a periodic basis. At
such time that the Company believes that it is more likely than not that a
portion of the deferred tax asset will be realized, the valuation allowance
will be reduced.
POTENTIAL FLUCTUATIONS IN QUARTERLY OPERATING RESULTS. The Company's results
of operations historically have fluctuated on a quarterly basis due to
numerous factors. Factors that may affect operating results of the Company
materially and unpredictably include: the economic conditions in the
semiconductor and electronics industries generally and in the Company's
geographic markets; the relatively high average selling price of the Company's
products; the relatively small number of transactions; the size and timing of
receipt of orders from customers; the timing of operating expenditures; the
level of market acceptance for the Company's products; the successful
management of systems integration projects; reduced margins from systems
integration projects; changes in average selling price and product mix;
exchange rate fluctuations; increased competition; new product announcements
and releases by the Company and its competitors and subsequent deferrals in
sales orders as new or competitive products are evaluated by prospective
customers; the timing of co-development products with customers; gain or loss
of significant customers; expense levels; renewal of maintenance contracts;
pricing changes by the Company or its competitors; and personnel changes. Any
unfavorable change in these or other factors could have a material adverse
effect on the Company's operating results for a particular quarter.
The Company's expense levels will be based, in part, on expectations of future
revenues. If revenue levels in a particular quarter do not meet expectations,
operating results could be adversely affected. The slowdown in the
semiconductor industry and in the construction of new wafer fabrication
facilities has resulted in Consilium experiencing rescheduled orders, a
reduction or delay in orders for WorkStream DFS and lower than expected demand
for systems integration services; there can be no assurance that this slowdown
will not continue. Quarterly revenue and operating results will depend on the
volume and timing of orders received during the quarter, which are difficult
to forecast accurately. Historically, the Company has often recognized a
substantial portion of its license revenues in the last month of the quarter,
with these revenues frequently concentrated in the last two weeks of the
quarter. Operating results would be disproportionately affected by a
reduction in revenue because only a small portion of the Company's expense
vary with its revenue. In addition, the Company's margins in its systems
integration projects are typically lower than its margins from sales of its
WorkStream products and maintenance contracts for such products. The Company
expects that revenues from its systems integration services will continue to
increase as a percentage of overall revenues, and that its overall margins
will correspondingly decrease. Additional risk factors are set forth in the
Company's Annual Report on Form 10-K for the year ended October 31, 1997.
Operating results in any period should not be considered indicative of the
results to be expected for any future period, and there can be no assurance
that the Company's revenues will increase or that the Company will achieve
profitability.
LIQUIDITY AND CAPITAL RESOURCES. As of July 31, 1998, the Company had
$6,665,000 in cash and cash equivalents, as compared with $7,865,000 in cash
and cash equivalents and short term investments at October 31, 1997. The
Company used $548,000 for operating activities during the nine months ended
July 31, 1998, compared with $3,342,000 used for operating activities in the
same period of the previous fiscal year. The decrease was due primarily to a
decrease in net loss, partially offset by changes in the balances of operating
assets and liabilities.
Net cash used for investing activities was $182,000 during the first
nine months of fiscal 1998, as compared with $437,000 of net cash used for
investing activities for the same period in fiscal 1997. The $182,000 net
cash used for investing activities during the nine months ended July 31, 1998
represented cash received from the sale of the Health Care and Process
business unit, offset by capital expenditures, capitalized software
development costs, and FAST acquisition costs.
Net cash used for financing activities was $178,000 during the first
nine months of fiscal 1998, which represented proceeds from the issuance of
common stock, offset by preferred stock issuance costs.
Under the asset purchase agreement to purchase certain tangible and
intangible assets from FAST, the Company may be required to make additional
annual performance-based payments. Such performance-based payments will be
based upon specified percentages of systems integration and related services
net operating margin, and net product license and maintenance revenue
recognized by the Company in certain countries in Asia for a period of three
years ending on August 1, 2000, as follows: 45% of systems
integration/services net operating margin, 10% of product license net revenue,
and 2.5% of product maintenance net revenue. Such payments may be made in
cash or Common Stock, at the option of the Company. The first $1,500,000 of
the performance payments are guaranteed. As of July 31, 1998, $1,200,000 of
these guaranteed performance payments have been paid, $900,000 by issuance of
234,192 shares of the Common Stock and one cash payment of $300,000. The last
guaranteed performance payment of $300,000 of cash has been paid in August
1998. FAST has certain registration rights with respect to the Common Stock
issued. Shares of common stock issued in fiscal 1997 have been registered by
the Company in fiscal 1998.
As of April 30, 1998, the Company had $3,051,000 outstanding under the Line of
Credit Agreement dated April 1, 1997 with its existing bank. On July 24, 1998,
the Company entered into a new banking arrangement and paid off all amounts
due under the above mentioned Line of Credit Agreement. Under this new
facility, the Company can borrow up to $6,500,000, including a $2,750,000
three year term loan (the "Term Loan Agreement"), and an additional line of
credit (the "Revolving Facility Agreement") of up to $3,750,000 based on
eligible accounts receivable. The term loan agreement is secured by
substantially all of the Company's assets, bears interest at 1.0% above the
prime rate per annum (9.5% at July 31, 1998) and expires on July 24, 2001.
The revolving facility agreement is secured by substantially all of the
Company's assets, bears interest at 0.5% above the prime rate per annum (9.0%
at July 31, 1998) and expires on July 24, 1999. At July 31, 1998, $2,750,000
was outstanding under the Term Loan Agreement and no borrowings were
outstanding under the Revolving Facility Agreement. The Term Loan and
Revolving Facility Agreements require the Company to maintain certain
financial covenants. The Company is in compliance with all financial
covenants.
Management believes the existing cash and cash equivalents including
cash generated from operations combined with its borrowing capacity under the
new Term Loan and Revolving Facility Agreement will be sufficient to meet the
Company's working capital and capital expenditure requirements for the next
twelve months.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Not applicable
<PAGE>
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
-----------------
None
Item 2. Changes in Securities
---------------------
None
Item 3. Defaults upon Senior Securities
-------------------------------
None
Item 4. Submission of Matters to a Vote of Security Holders
---------------------------------------------------
None
Item 5. Other Information
-----------------
None
Item 6. Exhibits and Reports on
Form 8-K
-----------------------
(a). List of Exhibits
<TABLE>
<CAPTION>
Exhibit
Number Exhibit Title
- - ---------- --------------------------
<S> <C>
3.1 Certificate of Incorporation of the Company.(2)
3.2 By-Laws of the Company.(2)
3.3 Certificate of Designation of Series A Convertible Preferred
Stock.(3)
4.1 Form of Warrant Agreement dated April 1, 1997 between the
Company and Imperial Bank.(3)
4.2 Form of 8% Convertible Preferred Stock Subscription Agreement for
the Sale of an Aggregate $3 million worth of Preferred Shares to
certain private institutional investors dated August 19, 1997.(3)
4.3 Form of Warrant Agreement dated August 19, 1997 between the
Company and certain placement agents.(3)
10.2 Master Lease Agreement, dated December 2, 1988, between the
Company and General Electric Capital Corporation, with
schedules.(1)
10.3 Letter Agreement, dated July 22, 1987, with respect to the
employment of Thomas Tomasetti.(1,6)
10.5 Agreement between the Company and Honeywell, Inc., Industrial
Automation and Control, dated April 1, 1993.(2,5)
10.6 Form of Director and Officer Indemnity Agreement.(4)
10.7 Amended and Restated 1983 Stock Option Plan.(6,7)
10.8 Forms of Stock Option Agreement used in conjunction with the
1983 Stock Option Plan.(6,7)
10.9 1990 Outside Director's Stock Option Plan.(6,7)
10.10 Forms of Outside Directors Stock Option Agreement used in
conjunction with the 1990 Outside Director's Stock Option Plan.
(6,7)
10.11 Lease agreement for the Company's principal facility, dated
August 2, 1995, among the Company and The Prudential Insurance
Company of America.(7)
10.12 Letter Agreement, dated August 5, 1994, with respect to the
employment of Edward Norton.(6,7)
10.13 Letter Agreement, dated September 28, 1994, with respect to the
employment of Richard Van Hoesen.(6,7)
10.14 Letter Agreement, dated July 12, 1996 , with respect to the
resignation of Thomas Tomasetti.(6,8)
10.15 Letter Agreement dated June 3, 1996, with respect to the
employment of Laurence R. Hootnick.(6,8)
10.16 Asset Purchase Agreement for the acquisition of the Taiwan
operations of Systematic Designs International, Inc. dated July
2, 1996.(10)
10.17 Letter Agreement dated August 6, 1996, with respect to the
employment of Wynn Bowman.(6,9)
10.18 Letter Agreement dated August 6, 1996, with respect to the
employment of Michael J. Field.(6,9)
10.19 Change of Control Agreement with Laurence R. Hootnick.(6,11)
10.20 Change of Control Agreement with Jonathan J. Golovin.(6,11)
10.21 Form of Change of Control Agreement for Executive Officers.(6,11)
10.22 1996 Stock Option Plan and Forms of Stock Option Agreement.(6,11)
10.23 Security and Loan Agreement dated April 1, 1997 between the
Company and Imperial Bank.(3)
10.24 Settlement Agreement, dated January 30, 1998, among the Company,
Consilium Taiwan, Inc., Systematic Designs International, Inc.
and Jen-Shih Jessi Niou.(12)
10.25 Asset Purchase Agreement, dated February 19, 1998, among the
Company, Base Ten FlowStream, Inc. and Base Ten Systems, Inc.(13)
10.26 Letter Agreement dated January 13, 1998, with respect to the
employment of Jim Macek.(6,16)
10.27 Asset Purchase Agreement for the acquisition of FAST Associates,
Pte. Dated July 31, 1997. (14)
10.28 Agreement between the Company and HCL America, Inc., dated
May 21, 1997. (5,15)
10.29 Security and Loan Agreement dated July 24, 1998
between the Company and Venture Banking Group.
27 Financial Data Schedule (available in EDGAR format only).
</TABLE>
(1) Incorporated by reference from exhibits of the same number in
Registrant's Registration Statement on Form S-1 (File No. 33-27947),
effective May 9, 1989.
(2) Incorporated by reference from exhibits 3.1, 3.2 and 10.19,
respectively, in Registrant's Quarterly Report on Form 10-Q for the
Quarter ended April 30, 1993.
(3) Incorporated by reference from exhibits of the same number in
Registrant's Quarterly Report on Form 10-Q for the Quarter ended July
31, 1997.
(4) Incorporated by reference from exhibit 10.6 in Registrant's Quarterly
Report on Form 10-Q for the Quarter ended July 31, 1994.
(5) The Securities and Exchange Commission has granted confidential
treatment for portions of this document.
(6) Compensatory or employment arrangement.
(7) Incorporated by reference from exhibits of the same number in
Registrant's Annual Report on Form 10-K for the Year ended October 31,
1995.
(8) Incorporated by reference from exhibits of the same number in
Registrant's Quarterly Report on Form 10-Q for the Quarter ended July
31, 1996.
(9) Incorporated by reference from exhibits of the same number in
Registrant's Annual Report on Form 10-K for the Year ended October 31,
1996.
(10) Incorporated by reference from exhibit 2.1 in Registrant's Report on
Form 8-K filed on July 26, 1996 for the acquisition of the Taiwan
operations of Systematic Designs International, Inc.
(11) Incorporated by reference from exhibits of the same number in
Registrant's Quarterly Report on Form 10-Q for the Quarter ended
January 31, 1997.
(12) Incorporated by reference from exhibits of the same number in
Registration Statement on Form S-1 (File No. 333-44743), filed January
22, 1998.
(13) Incorporated by reference from exhibit 2.1 in Registrant's Report on
Form 8-K filed on March 3, 1998 for the sale of assets of the
Healthcare Products and Process Industries Group.
(14) Incorporated by reference from exhibit 2.1 in Registrant's Quarterly
Report on Form 10-Q for the Quarter ended July 31, 1997.
(15) Incorporated by reference from exhibit 10.24 in Registrant's Annual
Report on Form 10-K/A for the Year ended October 31, 1997.
(16) Incorporated by reference from exhibits of the same number in
Registrant's Quarterly Report on Form 10-Q for the Quarter ended
January 31, 1998.
(b). Reports on Form 8-K
None
<PAGE>
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, a duly authorized officer and the chief financial officer of the
registrant.
CONSILIUM, INC.
------------------------------
(Registrant)
Date September 11, 1998 by: /s/ Clifton Wong
------------------------ ---------------------------
Clifton Wong
Vice President, Finance and
Chief Financial Officer
VENTURE BANKING GROUP
LOAN AND SECURITY AGREEMENT
DATED AS OF July 24, 1998
AGREEMENT
This Loan and Security Agreement ("Agreement") is made and
entered into as of July 24, 1998, by and between VENTURE BANKING GROUP, A
DIVISION OF CUPERTINO NATIONAL BANK ("Bank") and CONSILIUM, INC. ("Borrower").
RECITALS
Borrower wishes to obtain credit from time to time from Bank, and
Bank desires to extend credit to Borrower. This Agreement sets forth
the terms on which Bank will advance credit to Borrower, and Borrower
will repay the amounts owing to Bank.
AGREEMENT
The parties agree as follows:
1. DEFINITIONS AND CONSTRUCTION.
1.1 Definitions. As used in this Agreement, the
following terms shall have the following definitions:
"Accounts" means all presently existing and hereafter
arising accounts, contract rights, and all other forms of obligations
owing to Borrower arising out of the sale or lease of goods (including,
without limitation, the licensing of software and other technology) or
the rendering of services by Borrower, whether or not earned by
performance, and any and all credit insurance, guaranties, and other
security therefor, as well as all merchandise returned to or reclaimed
by Borrower and Borrower's Books relating to any of the foregoing.
"Advance" or "Advances" means an Advance under the
Revolving Facility.
"Affiliate" means, with respect to any Person, any Person
that owns or controls directly or indirectly such Person, any Person
that controls or is controlled by or is under common control with such
Person, and each of such Person's senior executive officers, directors,
and partners.
"Approved Foreign Accounts" means Accounts with respect to
which the account debtor does not have its principal place of business
in the United States and that are (1) approved by Bank on a case-by-
case basis; or (2) not excluded by any of clauses (a) through (k))
under the defined term, "Eligible Accounts."
"Bank Expenses" means all reasonable costs or expenses
(including reasonable attorneys' fees and expenses) incurred, subject
to Section 2.6(c), in connection with the preparation, negotiation,
administration, and enforcement of the Loan Documents; and Bank's
reasonable attorneys' fees and expenses incurred in amending, enforcing
or defending the Loan Documents, whether or not suit is brought.
"Borrower's Books" means all of Borrower's books and
records including ledgers; records concerning Borrower's assets or
liabilities, the Collateral, business operations or financial
condition; and all computer programs, or tape files, and the equipment
containing such information.
"Borrowing Base" has the meaning set forth in Section 2.1
hereof.
"Business Day" means any day that is not a Saturday,
Sunday, or other day on which banks in the State of California are
authorized or required to close.
"Change in Control" means the occurrence of: (i) any
Person, or two or more Persons acting in concert, acquiring beneficial
ownership (within the meaning of Rule 13d-3 of the Securities and
Exchange Commission under the Securities Exchange Act of 1934, as
amended), directly or indirectly, of securities of Borrower (or other
securities convertible into such securities) representing greater than
50% of the combined voting power of all securities of Borrower
entitled to vote in the election of directors; (ii) any Person, or two
or more Persons acting in concert, acquiring by contract or otherwise,
or entering into a contract or arrangement which, upon consummation,
will result in its or their acquisition of, or control over, securities
of Borrower (or other securities convertible into such securities)
representing greater than 50% of the combined voting power of all
securities of Borrower entitled to vote in the election of directors;
or (iii) a material change in Borrower's chief executive officer, chief
financial officer or chief administrative officer.
"Closing Date" means the date of this Agreement.
"Code" means the California Uniform Commercial Code.
"Collateral" means the property described on Exhibit A
attached hereto.
"Contingent Obligation" means, as applied to any Person,
any direct or indirect liability, contingent or otherwise, of that
Person with respect to (i) any indebtedness, lease, dividend, letter of
credit or other obligation of another, including, without limitation,
any such obligation directly or indirectly guaranteed, endorsed,
co-made or discounted or sold with recourse by that Person, or in
respect of which that Person is otherwise directly or indirectly
liable; (ii) any obligations with respect to undrawn letters of credit
issued for the account of that Person; and (iii) all obligations
arising under any interest rate, currency or commodity swap agreement,
interest rate cap agreement, interest rate collar agreement, or other
agreement or arrangement designated to protect a Person against
fluctuation in interest rates, currency exchange rates or commodity
prices; provided, however, that the term "Contingent Obligation" shall
not include endorsements for collection or deposit in the ordinary
course of business. The amount of any Contingent Obligation shall be
deemed to be an amount equal to the stated or determined amount of the
primary obligation in respect of which such Contingent Obligation is
made or, if not stated or determinable, the maximum reasonably
anticipated liability in respect thereof as determined by such Person
in good faith; provided, however, that such amount shall not in any
event exceed the maximum amount of the obligations under the guarantee
or other support arrangement.
"Current Assets" means, as of any applicable date, all
amounts that should, in accordance with GAAP, be included as current
assets on the consolidated balance sheet of Borrower and its
Subsidiaries as at such date.
"Current Liabilities" means, as of any applicable date, all
amounts that should, in accordance with GAAP, be included as current
liabilities on the consolidated balance sheet of Borrower and its
Subsidiaries, as at such date, plus, to the extent not already included
therein, all outstanding Advances made under this Agreement, including
all Indebtedness that is payable upon demand or within one year from
the date of determination thereof unless such Indebtedness is renewable
or extendable at the option of Borrower or any Subsidiary to a date
more than one year from the date of determination, but excluding
Subordinated Debt.
"Daily Balance" means the amount of the Obligations owed at
the end of a given day.
"Eligible Accounts" means those Accounts that arise in the
ordinary course of Borrower's business that comply with all of
Borrower's representations and warranties to Bank set forth in
Section 5.4; provided, that upon an Event of Default, standards of
eligibility may be fixed and revised from time to time by Bank in
Bank's reasonable judgment and upon notification thereof to Borrower in
accordance with the provisions hereof. Eligible Accounts shall also
include Accounts of Borrower's wholly owned subsidiaries domiciled in
Taiwan and Germany not otherwise ineligible hereunder. Unless
otherwise agreed to by Bank, Eligible Accounts shall not include the
following:
(a) Accounts that the account debtor has failed to
pay within ninety (90) days of invoice date; provided, however, that
Approved Foreign Accounts shall be deemed Eligible Accounts so long as
the account debtor has not failed to pay within one hundred and twenty
(120) days of the invoice date;
(b) Accounts with respect to an account debtor
twenty-five percent (25%) of whose Accounts the account debtor has
failed to pay within ninety (90) days of invoice date;
(c) Accounts with respect to which the account
debtor is an officer, employee, or agent of Borrower;
(d) Accounts with respect to which goods are placed
on consignment, guaranteed sale, sale or return, sale on approval, bill
and hold, or other terms by reason of which the payment by the account
debtor may be conditional;
(e) Accounts with respect to which the account
debtor is an Affiliate of Borrower;
(f) Accounts with respect to which the account
debtor is a federal, state, or local governmental entity or any
department, agency, or instrumentality thereof.
(g) Accounts with respect to which Borrower is
liable to the account debtor for goods sold or services rendered by the
account debtor to Borrower, but only to the extent of any amounts owing
to the account debtor against amounts owed to Borrower;
(h) Accounts with respect to an account debtor,
including Subsidiaries and Affiliates, whose total obligations to
Borrower exceed twenty-five percent (25%) of all Accounts, to the
extent such obligations exceed the aforementioned percentage, except as
approved in writing by Bank;
(i) Accounts with respect to which the account
debtor disputes liability or makes any claim with respect thereto as to
which Bank believes, in its sole discretion, that there may be a basis
for dispute (but only to the extent of the amount subject to such
dispute or claim), or is subject to any Insolvency Proceeding, or
becomes insolvent, or goes out of business;
(j) Accounts with respect to which the account
debtor is a distributor, unless pre-approved by Bank in writing; and
(k) Accounts the collection of which Bank, in its
commercially reasonable discretion, determines to be doubtful.
"Equipment" means all present and future machinery,
equipment, tenant improvements, furniture, fixtures, vehicles, tools,
parts and attachments in which Borrower has any interest.
"ERISA" means the Employment Retirement Income Security Act
of 1974, as amended, and the regulations thereunder.
"GAAP" means generally accepted accounting principles as in
effect from time to time.
"Indebtedness" means (a) all indebtedness for borrowed
money or the deferred purchase price of property or services, including
without limitation reimbursement and other obligations with respect to
surety bonds and letters of credit, (b) all obligations evidenced by
notes, bonds, debentures or similar instruments, (c) all capital lease
obligations and (d) all Contingent Obligations.
"Insolvency Proceeding" means any proceeding commenced by
or against any person or entity under any provision of the United
States Bankruptcy Code, as amended, or under any other bankruptcy or
insolvency law, including assignments for the benefit of creditors,
formal or informal moratoria, compositions, extension generally with
its creditors, or proceedings seeking reorganization, arrangement, or
other relief.
"Inventory" means all present and future inventory in which
Borrower has any interest, including merchandise, raw materials, parts,
supplies, packing and shipping materials, work in process and finished
products intended for sale or lease or to be furnished under a contract
of service, of every kind and description now or at any time hereafter
owned by or in the custody or possession, actual or constructive, of
Borrower, including such inventory as is temporarily out of its custody
or possession or in transit and including any returns upon any accounts
or other proceeds, including insurance proceeds, resulting from the
sale or disposition of any of the foregoing and any documents of title
representing any of the above.
"Investment" means any beneficial ownership of (including
stock, partnership interest or other securities) any Person, or any
loan, advance or capital contribution to any Person.
"IRC" means the Internal Revenue Code of 1986, as amended,
and the regulations thereunder.
"Lien" means any mortgage, lien, deed of trust, charge,
pledge, security interest or other encumbrance.
"Loan Documents" means, collectively, this Agreement, any
note or notes executed by Borrower, and any other agreement entered
into between Borrower and Bank in connection with this Agreement, all
as amended or extended from time to time.
"material," "Material Adverse Change," and/or "Material
Adverse Effect" as each of those terms may appear in the Loan
Documents, shall mean, each in context, a negative result or potential
result arising directly or indirectly from facts that, in the totality
of the circumstances, Bank considers substantive and germane to (a) the
business, assets, operations, financial or other condition of Borrower
and its Subsidiaries, taken as a whole; (b) the ability of Borrower to
pay or perform in accordance with the terms of this Agreement or any
other Loan Document; or (c) the rights and remedies of Bank under this
Agreement or any of the Loan Documents.
"Maturity Date" means the later to occur of (i) the
Revolving Maturity Date; or (ii) the Term Loan Maturity Date.
"Negotiable Collateral" means all of Borrower's present and
future letters of credit of which it is a beneficiary, notes, drafts,
instruments, securities, documents of title, and chattel paper.
"Obligations" means all debt, principal, interest, Bank
Expenses and other amounts owed to Bank by Borrower pursuant to the
this Agreement or any other Agreement, whether absolute or contingent,
due or to become due, now existing or hereafter arising, including any
interest that accrues after the commencement of an Insolvency
Proceeding and including any debt, liability, or obligation owing from
Borrower to others that Bank my have obtained by assignment or
otherwise.
"Payment Date" means the last calendar day of each month.
"Periodic Payments" means all installments or similar
recurring payments that Borrower may now or hereafter become obligated
to pay to Bank pursuant to the terms and provisions of any instrument,
or agreement now or hereafter in existence between Borrower and Bank.
"Permitted Indebtedness" means:
(a) Indebtedness of Borrower in favor of Bank
arising under this Agreement or any other Loan Document;
(b) Indebtedness existing on the Closing Date and
disclosed in the Schedule;
(c) Subordinated Debt; and
(d) Indebtedness to trade creditors incurred in the
ordinary course of business.
"Permitted Investment" means:
(a) Investments existing on the Closing Date
disclosed in the Schedule;
(b) (i) marketable direct obligations issued or
unconditionally guaranteed by the United States of America or any
agency or any State thereof maturing within one (1) year from the date
of acquisition thereof, (ii) commercial paper maturing no more than one
(1) year from the date of creation thereof and currently having the
highest rating obtainable from either Standard & Poor's Corporation or
Moody's Investors Service, Inc., and (iii) certificates of deposit
maturing no more than one (1) year from the date of investment therein
issued by Bank; and
(c) acquisitions permitted pursuant to Section 7.3.
"Permitted Liens" means the following:
(a) Any Liens existing on the Closing Date and
disclosed in the Schedule or arising under this Agreement or the other
Loan Documents;
(b) Liens for taxes, fees, assessments or other
governmental charges or levies, either not delinquent or being
contested in good faith by appropriate proceedings, provided the same
have no priority over any of Bank's security interests;
(c) Liens (i) upon or in any equipment acquired or
held by Borrower or any of its Subsidiaries to secure the purchase
price of such equipment or indebtedness incurred solely for the purpose
of financing the acquisition of such equipment, or (ii) existing on
such equipment at the time of its acquisition, provided that the Lien
is confined solely to the property so acquired and improvements
thereon, and the proceeds of such equipment;
(d) Liens incurred in connection with the
extension, renewal or refinancing of the indebtedness secured by Liens
of the type described in clauses (a) and (c) above, provided that any
extension, renewal or replacement Lien shall be limited to the property
encumbered by the existing Lien and the principal amount of the
indebtedness being extended, renewed or refinanced does not increase.
"Person" means any individual, sole proprietorship,
partnership, limited liability company, joint venture, trust,
unincorporated organization, association, corporation, institution,
public benefit corporation, firm, joint stock company, estate, entity
or governmental agency.
"Prime Rate" means the variable rate of interest, per
annum, most recently published in the Money Rate Section of the West
Coast Edition of the Wall Street Journal, as the "prime rate," whether
or not such published rate is the lowest rate available from Bank.
When a range of rates is published, the higher of the rates shall apply
at the time the rate is changed.
"Quick Assets" means, at any date as of which the amount
thereof shall be determined, the consolidated cash, cash equivalents,
accounts receivable and investments, with maturities not to exceed 90
days, of Borrower determined in accordance with GAAP.
"Responsible Officer" means each of the Chief Executive
Officer, the Chief Financial Officer and the Controller of Borrower.
"Revolving Facility" means Three Million Seven Hundred
Fifty Thousand Dollars ($3,750,000).
"Revolving Facility Availability" means the difference
between the maximum availability and the principal amount of
outstanding Advances.
"Revolving Facility Obligations" means all debt, principal,
interest, Bank Expenses and other amounts owed to Bank by Borrower
pursuant to the Revolving Facility, whether absolute or contingent, due
or to become due, now existing or hereafter arising, including any
interest that accrues after the commencement of an Insolvency
Proceeding.
"Revolving Maturity Date" means July 24, 1999.
"Schedule" means the schedule of exceptions attached
hereto, if any.
"Subordinated Debt" means any debt incurred by Borrower
that is subordinated to the debt owing by Borrower to Bank on terms
acceptable to Bank (and identified as being such by Borrower and Bank).
"Subsidiary" means any corporation or partnership in which
(i) any general partnership interest or (ii) more than 50% of the stock
of which by the terms thereof ordinary voting power to elect the Board
of Directors, managers or trustees of the entity shall, at the time as
of which any determination is being made, be owned by Borrower, either
directly or through an Affiliate.
"Tangible Net Worth" means at any date as of which the
amount thereof shall be determined, the consolidated total assets of
Borrower and its Subsidiaries minus, without duplication, (i) the sum
of any amounts attributable to (a) goodwill, (b) intangible items such
as unamortized debt discount and expense, patents, trade and service
marks and names, copyrights and research and development expenses
except prepaid expenses, and (c) all reserves not already deducted from
assets, and (ii) Total Liabilities.
"Total Liabilities" means at any date as of which the
amount thereof shall be determined, all obligations that should, in
accordance with GAAP be classified as liabilities on the consolidated
balance sheet of Borrower, including in any event all Indebtedness, but
specifically excluding Subordinated Debt.
1.2 Accounting Terms. All accounting terms not
specifically defined herein shall be construed in accordance with GAAP
and all calculations made hereunder shall be made in accordance with
GAAP. When used herein, the terms "financial statements" shall include
the notes and schedules thereto.
2. Loan and Terms of Payment
2.1 Advances. Subject to and upon the terms and
conditions of this Agreement, Bank agrees to make Advances to Borrower
in an aggregate amount not to exceed the Revolving Facility or the
Borrowing Base, whichever is less (the "Maximum Availability"). For
purposes of this Agreement and subject to the Advance Limit (as defined
below), "Borrowing Base" shall mean an amount equal to eighty percent
(80%) of Eligible Accounts. Subject to the terms and conditions of
this Agreement, amounts borrowed pursuant to this Section 2.1
("Borrowings") may be repaid and reborrowed at any time during the term
of this Agreement.
(a) Notwithstanding any of the foregoing provisions
contained in this Agreement, with respect to Eligible Accounts which
arise from invoices issued by Borrower's wholly-owned Subsidiaries in
Taiwan and Germany, Bank shall make Advances to Borrower only to the
extent that such Advances do not exceed Seven Hundred Fifty Thousand
Dollars ($750,000) (the "Advance Limit"); provided, the Bank and
Borrower shall review the Advance Limit within ninety (90) days from
the date hereof and Bank shall make appropriate adjustments to the
Advance Limit as Bank shall in its sole and commercially reasonable
discretion deem appropriate, but in no event shall the Advance Limit be
less than $750,000.
(b) Whenever Borrower desires an Advance, Borrower
will notify Bank by facsimile transmission or telephone no later than
3:00 p.m. Pacific time, on the Business Day that the Advance is to be
made. Each such notification shall be promptly confirmed by a
Payment/Advance Form in substantially the form of Exhibit B hereto.
Bank is authorized to make Advances under this Agreement, based upon
instructions received from a Responsible Officer, or without
instructions if in Bank's discretion such Advances are necessary to
meet Obligations which have become due and remain unpaid. Bank shall
be entitled to rely on any telephonic notice given by a person who Bank
reasonably believes to be a Responsible Officer, and Borrower shall
indemnify and hold Bank harmless for any damages or loss suffered by
Bank as a result of such reliance. Bank will credit the amount of
Advances made under this Section 2.1 to Borrower's deposit account.
(c) The Revolving Facility shall terminate on the
Revolving Maturity Date, at which time all Advances under this
Section 2.1 and other amounts due under this Agreement (except as
otherwise expressly specified herein) shall be immediately due and
payable.
2.2 Term Loan.
(a) In order to repay all existing loans and
related indebtedness owed by Borrower to Imperial Bank, and
miscellaneous capital acquisitions, Bank hereby agrees to make a term
loan to Borrower on the Closing Date in an aggregate principal amount
of Two Million Seven Hundred Fifty Thousand Dollars ($2,750,000) (the
"Term Loan").
(b) Borrower shall pay thirty-six equal amortized
installments of principal plus interest in the amount of [payment
amount] (the "Term Loan Payment"). Each Term Loan Payment shall be due
and payable on the Payment Date during the term hereof. Borrower's
final Term Loan Payment, due on July 24, 2001 (the "Term Loan Maturity
Date"), shall include all outstanding Term Loan principal plus all
accrued interest not yet paid (the "Term Loan Balance").
(c) The Term Loan shall bear interest at a rate
equal to one (1.0) percentage point above the Prime Rate.
2.3 Overadvances. If, at any time during which Borrower
is required to provide a Borrowing Base Certificate or for any reason,
the amount of Revolving Facility Obligations owed by Borrower exceeds
the Maximum Availability (the "Overadvance"), Borrower shall
immediately pay to Bank, in cash, the amount of such Overadvance;
provided, however, that the amount of Revolving Facility Obligations
owed by Borrower may exceed the Maximum Availability so long as such
Overadvance (i) occurs during the second month of any fiscal quarter;
(ii) does not exceed Two Million Dollars ($2,000,000); (iii) does not
remain unpaid for more than thirty (30) consecutive days; and (iv) is
supported by a cash deposit with Bank in an amount not less than one
hundred twenty-five percent (125%) of the amount of such Overadvance.
2.4 Interest Rates, Payments, and Calculations.
(a) Interest Rate. Any Advances shall bear
interest, on the average Daily Balance, at a rate equal to one-half
(0.5%) percentage point above the Prime Rate.
(b) Default Rate. All Obligations shall bear
interest, from and after the occurrence of an Event of Default, at a
rate equal to five (5) percentage points above the interest rate
applicable immediately prior to the occurrence of the Event of Default.
(c) Payments. Interest hereunder shall be due and
payable on the Payment Date during the term hereof. Bank shall, at its
option, charge such interest, all Bank Expenses, and all Periodic
Payments against any of Borrower's accounts with Bank, in which case
those amounts shall thereafter accrue interest at the rate then
applicable hereunder. Borrower hereby authorizes Bank to debit any
accounts with Bank, including, without limitation, Account Number
_____________________ for payments of principal and interest due on the
Obligations and any other amounts owing by Borrower to Bank. Bank will
notify Borrower of all debits that Bank makes against Borrower's
accounts. Any interest not paid when due shall be compounded by
becoming a part of the Obligations, and such interest shall thereafter
accrue interest at the rate then applicable hereunder.
(d) Computation. In the event the Prime Rate is
changed from time to time hereafter, the applicable rate of interest
hereunder shall be increased or decreased effective as of 12:01 a.m. on
the day the Prime Rate is changed, by an amount equal to such change in
the Prime Rate. All interest chargeable under the Loan Documents shall
be computed on the basis of a three hundred sixty (360) day year for
the actual number of days elapsed.
2.5 Crediting Payments. Prior to the occurrence of an
Event of Default, Bank shall credit a wire transfer of funds, check or
other item of payment to such deposit account or Obligation as Borrower
specifies. After the occurrence of an Event of Default, the receipt by
Bank of any wire transfer of funds, check, or other item of payment
shall be immediately applied to conditionally reduce Obligations, but
shall not be considered a payment on account unless such payment is of
immediately available federal funds or unless and until such check or
other item of payment is honored when presented for payment.
Notwithstanding anything to the contrary contained herein, any wire
transfer or payment received by Bank or acknowledged by Bank as having
been sent via confirmation of a federal reserve wire number, after
12:00 noon Pacific time shall be deemed to have been received by Bank
as of the opening of business on the immediately following Business
Day. Whenever any payment to Bank under the Loan Documents would
otherwise be due (except by reason of acceleration) on a date that is
not a Business Day, such payment shall instead be due on the next
Business Day and shall not constitute an Event of Default, and
additional fees or interest, as the case may be, shall accrue and be
payable for the period of such extension.
2.6 Fees. Borrower shall pay to Bank the following:
(a) Facility Fee. A Facility Fee equal to Thirty-
Two Thousand Five Hundred Dollars ($32,500), which fee shall be due on
or before the Closing Date and upon the Closing Date shall be fully
earned and non-refundable;
(b) Financial Examination and Appraisal Fees.
Bank's customary fees and out-of-pocket expenses for Bank's audits of
Borrower's Accounts (not to exceed $800 per day for the Initial Audit
(as defined below)), and for each appraisal of Collateral and financial
analysis and examination of Borrower performed from time to time by
Bank or its agents;
(c) Bank Expenses. Upon the date hereof, all Bank
Expenses incurred through the Closing Date, including reasonable
attorneys' fees and expenses up to Seven Thousand Five Hundred Dollars
($7,500), and, after the date hereof, all Bank Expenses, including
reasonable attorneys' fees and expenses as and when they become due.
2.7 Additional Costs. In case any law, regulation,
treaty or official directive or the interpretation or application
thereof by any court or any governmental authority charged with the
administration thereof or the compliance with any guideline or request
of any central bank or other governmental authority (whether or not
having the force of law), in each case after the date of this
Agreement:
(a) subjects Bank to any tax with respect to
payments of principal or interest or any other amounts payable
hereunder by Borrower or otherwise with respect to the transactions
contemplated hereby (except for taxes on the overall net income of Bank
imposed by the United States of America or any political subdivision
thereof);
(b) imposes, modifies or deems applicable any
deposit insurance, reserve, special deposit or similar requirement
against assets held by, or deposits in or for the account of, or loans
by, Bank; or
(c) imposes upon Bank any other condition with
respect to its performance under this Agreement,
(d) and the result of any of the foregoing is to
increase the cost to Bank, reduce the income receivable by Bank or
impose any expense upon Bank with respect to any loans hereunder, Bank
shall notify Borrower thereof. Borrower agrees to pay to Bank the
amount of such increase in cost, reduction in income or additional
expense as and when such cost, reduction or expense is incurred or
determined, upon presentation by Bank of a statement of the amount and
setting forth Bank's calculation thereof, all in reasonable detail,
which statement shall be deemed true and correct absent manifest error.
2.8 Term. Except as otherwise set forth herein, this
Agreement shall become effective on the Closing Date and, subject to
Section 12.7, shall continue in full force and effect for a term ending
on the Maturity Date. Notwithstanding the foregoing, Bank shall have
the right to terminate its obligation to make Advances under this
Agreement immediately and without notice upon the occurrence and during
the continuance of an Event of Default. Notwithstanding termination,
Bank's Lien on the Collateral shall remain in effect for so long as any
Obligations are outstanding.
3. CONDITIONS OF LOANS
3.1 Conditions Precedent to Initial Advance. The
obligation of Bank to make the initial Advance is subject to the
condition precedent that Bank shall have received, in form and
substance satisfactory to Bank, the following:
(a) this Agreement;
(b) a Revolving Promissory Note made by Borrower in
favor of Bank in the form attached hereto as Exhibit E;
(c) a Term Loan Promissory Note made by Borrower in
favor of Bank in the form attached hereto as Exhibit F;
(d) a certificate of the Secretary of Borrower with
respect to incumbency and resolutions authorizing the execution and
delivery of this Agreement;
(e) a collateral assignment, patent mortgage and
security agreement;
(f) financing statements (Forms UCC-1);
(g) insurance certificate;
(h) payment of the fees and Bank Expenses then due
specified in Section 2.5 hereof;
(i) completion of an accounts receivable audit with
results satisfactory to Bank (the "Initial Audit"); and
(j) such other documents, and completion of such
other matters, as Bank may reasonably deem necessary or appropriate.
3.2 Conditions Precedent to All Advances. The obligation
of Bank to make each Advance, including the initial Advance, is further
subject to the following conditions:
(a) timely receipt by Bank of the Payment/Advance
Form as provided in Section 2.1; and
(b) the representations and warranties contained in
Section 5 shall be true and correct in all material respects on and as
of the date of such Payment/Advance Form and on the effective date of
each Advance as though made at and as of each such date, and no Event
of Default shall have occurred and be continuing, or would result from
such Advance. The making of each Advance shall be deemed to be a
representation and warranty by Borrower on the date of such Advance as
to the accuracy of the facts referred to in this Section 3.2(b).
4. CREATION OF SECURITY INTEREST
4.1 Grant of Security Interest. Borrower grants and
pledges to Bank a continuing security interest in all presently
existing and hereafter acquired or arising Collateral in order to
secure prompt repayment of any and all Obligations and in order to
secure prompt performance by Borrower of each of its covenants and
duties under the Loan Documents. Except as set forth in the Schedule,
such security interest constitutes a valid, first priority security
interest in the presently existing Collateral, and will constitute a
valid, first priority security interest in Collateral acquired after
the date hereof. Borrower acknowledges that Bank may place a "hold" on
any deposit account pledged as Collateral to secure the Obligations.
4.2 Delivery of Additional Documentation Required.
Borrower shall from time to time execute and deliver to Bank, at the
request of Bank, all Negotiable Collateral, all financing statements
and other documents that Bank may reasonably request, in form
satisfactory to Bank, to perfect and continue perfected Bank's security
interests in the Collateral and in order to fully consummate all of the
transactions contemplated under the Loan Documents.
4.3 Right to Inspect. Bank (through any of its officers,
employees, or agents) shall have the right, upon reasonable prior
notice, from time to time during Borrower's usual business hours, to
inspect Borrower's Books and to make copies thereof and to check, test,
and appraise the Collateral in order to verify Borrower's financial
condition or the amount, condition of, or any other matter relating to,
the Collateral.
5. REPRESENTATIONS AND WARRANTIES
Borrower represents and warrants as follows:
5.1 Due Organization and Qualification. Borrower and
each Subsidiary is a corporation duly existing and in good standing
under the laws of its state of incorporation and qualified and licensed
to do business in, and is in good standing in, any state in which the
conduct of its business or its ownership of property requires that it
be so qualified.
5.2 Due Authorization; No Conflict. The execution,
delivery, and performance of the Loan Documents are within Borrower's
powers, have been duly authorized, and are not in conflict with nor
constitute a breach of any provision contained in Borrower's
Certificate of Incorporation or Bylaws, nor will they constitute an
event of default under any material agreement to which Borrower is a
party or by which Borrower is bound. Borrower is not in default under
any agreement to which it is a party or by which it is bound, which
default could have a Material Adverse Effect.
5.3 No Prior Encumbrances. Borrower has good and
indefeasible title to the Collateral, free and clear of Liens, except
for Permitted Liens. Notwithstanding anything to the contrary stated
herein, Borrower makes no representations in this Section 5.3 or
elsewhere that any of the Collateral, except to the best of Borrower's
knowledge, does not infringe upon any third party's patent rights.
5.4 Bona Fide Eligible Accounts. The Eligible Accounts
are bona fide existing obligations. The property giving rise to such
Eligible Accounts has been delivered to the account debtor or to the
account debtor's agent for immediate shipment to and unconditional
acceptance by the account debtor. Borrower has not received notice of
actual or imminent Insolvency Proceeding of any account debtor that is
included in any Borrowing Base Certificate as an Eligible Account.
5.5 Merchantable Inventory. All Inventory is in all
material respects of good and marketable quality, free from all
material defects.
5.6 Name; Location of Chief Executive Office. Except as
disclosed in the Schedule, Borrower has not done business under any
name other than that specified on the signature page hereof. The chief
executive office of Borrower is located at the address indicated in
Section 10 hereof.
5.7 Litigation. Except as set forth in the Schedule and
Borrower's public filings with the Securities and Exchange Commission,
there are no actions or proceedings pending by or against Borrower or
any Subsidiary before any court or administrative agency in which an
adverse decision could have a Material Adverse Effect or a material
adverse effect on Borrower's interest or Bank's security interest in
the Collateral. Borrower does not have knowledge of any such pending
or threatened actions or proceedings.
5.8 No Material Adverse Change in Financial Statements.
All consolidated financial statements related to Borrower and any
Subsidiary that have been delivered by Borrower to Bank fairly present
in all material respects Borrower's consolidated financial condition as
of the date thereof and Borrower's consolidated results of operations
for the period then ended. There has not been a material adverse
change in the consolidated financial condition of Borrower since the
date of the most recent of such financial statements submitted to Bank.
5.9 Solvency. Borrower is solvent and able to pay its
debts (including trade debts) as they mature.
5.10 Regulatory Compliance. Borrower and each Subsidiary
has met the minimum funding requirements of ERISA with respect to any
employee benefit plans subject to ERISA. No event has occurred
resulting from Borrower's failure to comply with ERISA that is
reasonably likely to result in Borrower's incurring any liability that
could have a Material Adverse Effect. Borrower is not an "investment
company" or a company "controlled" by an "investment company" within
the meaning of the Investment Company Act of 1940. Borrower is not
engaged principally, or as one of the important activities, in the
business of extending credit for the purpose of purchasing or carrying
margin stock (within the meaning of Regulations T and U of the Board of
Governors of the Federal Reserve System). Borrower has complied with
all the provisions of the Federal Fair Labor Standards Act. Borrower
has not violated any statutes, laws, ordinances or rules applicable to
it, violation of which could have a Material Adverse Effect.
5.11 Environmental Condition. Except as disclosed on
Schedule C, attached hereto and incorporated herein by this reference,
none of Borrower's or any Subsidiary's properties or assets has ever
been used by Borrower or any Subsidiary or, to the best of Borrower's
knowledge, by previous owners or operators, in the disposal of, or to
produce, store, handle, treat, release, or transport, any hazardous
waste or hazardous substance other than in accordance with applicable
law; to the best of Borrower's knowledge, none of Borrower's properties
or assets has ever been designated or identified in any manner pursuant
to any environmental protection statute as a hazardous waste or
hazardous substance disposal site, or a candidate for closure pursuant
to any environmental protection statute; no lien arising under any
environmental protection statute has attached to any revenues or to any
real or personal property owned by Borrower or any Subsidiary; and
neither Borrower nor any Subsidiary has received a summons, citation,
notice, or directive from the Environmental Protection Agency or any
other federal, state or other governmental agency concerning any action
or omission by Borrower or any Subsidiary resulting in the releasing,
or otherwise disposing of hazardous waste or hazardous substances into
the environment.
5.12 Taxes. Borrower and each Subsidiary has filed or
caused to be filed all tax returns required to be filed, and has paid,
or has made adequate provision for the payment of, all taxes reflected
therein.
5.13 Subsidiaries. Except as disclosed on Schedule A
attached hereto and incorporated herein by this reference, Borrower
does not own any stock, partnership interest or other equity securities
of any Person, except for Permitted Investments.
5.14 Government Consents. Borrower and each Subsidiary
has obtained all consents, approvals and authorizations of, made all
declarations or filings with, and given all notices to, all
governmental authorities that are necessary for the continued operation
of Borrower's business as currently conducted.
5.15 Full Disclosure. No representation, warranty or
other statement made by Borrower in any certificate or written
statement furnished to Bank contains any untrue statement of a material
fact or omits to state a material fact necessary in order to make the
statements contained in such certificates or statements not misleading.
6. AFFIRMATIVE COVENANTS
Borrower covenants and agrees that, until payment in full of all
outstanding Obligations, and for so long as Bank may have any
commitment to make an Advance hereunder, Borrower shall do all of the
following:
6.1 Good Standing. Borrower shall maintain its and each
of its Subsidiaries' (i) corporate existence, except that any
Subsidiary may be merged into Borrower or any wholly-owned Subsidiary
of Borrower, and (ii) good standing in its jurisdiction of
incorporation and maintain qualification in each jurisdiction in which
the failure to so qualify could have a Material Adverse Effect.
Borrower shall maintain, and shall cause each of its Subsidiaries to
maintain, to the extent consistent with prudent management of
Borrower's business, in force all licenses, approvals and agreements,
the loss of which could have a Material Adverse Effect.
6.2 Government Compliance. Borrower shall meet, and
shall cause each Subsidiary to meet, the minimum funding requirements
of ERISA with respect to any employee benefit plans subject to ERISA.
Borrower shall comply, and shall cause each Subsidiary to comply, with
all statutes, laws, ordinances and government rules and regulations to
which it is subject, noncompliance with which could have a Material
Adverse Effect or a material adverse effect on the Collateral or the
priority of Bank's Lien on the Collateral.
6.3 Financial Statements, Reports, Certificates.
Borrower shall deliver to Bank: (a) as soon as available, but in any
event within twenty (20) days after the end of each month, a company
prepared consolidated balance sheet and income statement covering
Borrower's consolidated operations during such period, certified by an
officer of Borrower reasonably acceptable to Bank; (b) as soon as
available, but in any event within ninety (90) days after the end of
Borrower's fiscal year, audited consolidated financial statements of
Borrower prepared in accordance with GAAP, consistently applied,
together with an unqualified opinion on such financial statements of an
independent certified public accounting firm reasonably acceptable to
Bank; (c) within five (5) days of filing, copies of all statements,
reports and notices sent or made available generally by Borrower to its
security holders or to any holders of Subordinated Debt and all reports
on Form 10-K, 10-Q and 8-K filed with the Securities and Exchange
Commission; (d) promptly upon receipt of notice thereof, a report of
any legal actions pending or threatened against Borrower or any
Subsidiary that could result in damages or costs to Borrower or any
Subsidiary of One Hundred Thousand Dollars ($100,000) or more; and (e)
such budgets, sales projections, operating plans or other financial
information as Bank may reasonably request from time to time.
Within twenty (20) days after the last day of each month during
which Borrowings are outstanding, or if no Borrowings are outstanding,
within one (1) Business Day prior to requesting an Advance, Borrower
shall deliver to Bank a Borrowing Base Certificate signed by a
Responsible Officer in substantially the form of Exhibit C hereto,
together with aged listings of accounts receivable and accounts
payable.
Borrower shall deliver to Bank with the monthly financial
statements a Compliance Certificate signed by a Responsible Officer in
substantially the form of Exhibit D hereto.
Bank shall have a right from time to time hereafter to
audit Borrower's Accounts at Borrower's expense, provided that such
audits will be conducted no more often than every six (6) months unless
an Event of Default has occurred and is continuing.
6.4 Inventory; Returns. Borrower shall keep all
Inventory in good and marketable condition, free from all material
defects. Returns and allowances, if any, as between Borrower and its
account debtors shall be on the same basis and in accordance with the
usual customary practices of Borrower, as they exist at the time of the
execution and delivery of this Agreement. Borrower shall promptly
notify Bank of all returns and recoveries and of all disputes and
claims, where the return, recovery, dispute or claim involves more than
Fifty Thousand Dollars ($50,000).
6.5 Taxes. Except as disclosed on Schedule B attached
hereto and incorporated herein by this reference, Borrower shall make,
and shall cause each Subsidiary to make, due and timely payment or
deposit of all material federal, state, and local taxes, assessments,
or contributions required of it by law, and will execute and deliver to
Bank, on demand, appropriate certificates attesting to the payment or
deposit thereof; and Borrower will make, and will cause each Subsidiary
to make, timely payment or deposit of all material tax payments and
withholding taxes required of it by applicable laws, including, but not
limited to, those laws concerning F.I.C.A., F.U.T.A., state disability,
and local, state, and federal income taxes, and will, upon request,
furnish Bank with proof satisfactory to Bank indicating that Borrower
or a Subsidiary has made such payments or deposits; provided that
Borrower or a Subsidiary need not make any payment if the amount or
validity of such payment is contested in good faith by appropriate
proceedings and is reserved against (to the extent required by GAAP) by
Borrower.
6.6 Insurance.
(a) Borrower, at its expense, shall keep the
Collateral insured against loss or damage by fire, theft, explosion,
sprinklers, and all other hazards and risks, and in such amounts, as
ordinarily insured against by other owners in similar businesses
conducted in the locations where Borrower's business is conducted on
the date hereof. Borrower shall also maintain insurance relating to
Borrower's ownership and use of the Collateral in amounts and of a type
that are customary to businesses similar to Borrower's.
(b) All such policies of insurance shall be in such
form, with such companies, and in such amounts as reasonably
satisfactory to Bank. All such policies of property insurance shall
contain a lender's loss payable endorsement, in a form satisfactory to
Bank, showing Bank as an additional loss payee thereof and all
liability insurance policies shall show the Bank as an additional
insured, and shall specify that the insurer must give at least twenty
(20) days notice to Bank before canceling its policy for any reason.
Borrower shall deliver to Bank certified copies of such policies of
insurance and evidence of the payments of all premiums therefor. All
proceeds payable under any such policy shall, at the option of Bank, be
payable to Bank to be applied on account of the Obligations.
6.7 Principal Depository. Borrower shall maintain its
principal depository and operating accounts with Bank including,
without limitation, all of Borrower's domestic depository accounts.
Further, Borrower shall maintain at all times average monthly deposits
with Bank of at least Three Million Dollars ($3,000,000).
6.8 Debt-Net Worth Ratio. Borrower shall maintain, as of
the last day of each fiscal quarter, a ratio of Total Liabilities (net
of deferred revenue) to Tangible Net Worth of not more than 3.5 to 1.0.
6.9 Tangible Net Worth. Borrower shall maintain, as of
the last day of each fiscal quarter, a Tangible Net Worth of not less
than Two Million Five Hundred Dollars ($2,500,000).
6.10 Debt Coverage. Borrower shall maintain, as of the
last day of each fiscal quarter, either of the following:
(a) A Debt Service Ratio of at least 1.25 to 1.00.
"Debt Service Ratio" is defined as the sum of net profits after taxes
as measured on the last day of the preceding fiscal quarter plus
depreciation and amortization, divided by current portion of long term
debt for that quarter; or
(b) A Cash Ratio of at least 1.75 to 1.00. "Cash
Ratio" is defined as the sum of cash and cash equivalents plus the
Revolving Facility Availability, divided by the Term Loan Balance.
6.11 Registration of Intellectual Property Rights.
Borrower shall register or cause to be registered (to the extent not
already registered) with the United States Patent and Trademark Office
or the United States Copyright Office, as applicable, those
intellectual property rights listed on Exhibits A, B and C to the
Collateral Assignment, Patent Mortgage and Security Agreement delivered
to Bank by Borrower in connection with this Agreement within thirty
(30) days of the date of this Agreement. Borrower shall register or
cause to be registered with the United States Patent and Trademark
Office or the United States Copyright Office, as applicable, those
additional intellectual property rights developed or acquired by
Borrower from time to time in connection with any product prior to the
sale or licensing of such product to any third party, including without
limitation revisions or additions to the intellectual property rights
listed on such Exhibits A, B and C. Borrower shall execute and deliver
such additional instruments and documents from time to time as Bank
shall reasonably request to perfect Bank's security interest in such
additional intellectual property rights. Notwithstanding anything to
the contrary stated herein, Borrower shall not be required to register
Copyrights unless in keeping with its normal business policy.
6.12 Further Assurances. At any time and from time to
time Borrower shall execute and deliver such further instruments and
take such further action as may reasonably be requested by Bank to
effect the purposes of this Agreement.
6.13 Use of Proceeds. Borrower shall use the Advances for
working capital only.
7. NEGATIVE COVENANTS
Borrower covenants and agrees that, so long as any credit
hereunder shall be available and until payment in full of the
outstanding Obligations or for so long as Bank may have any commitment
to make any Advances, Borrower will not do any of the following:
7.1 Dispositions. Convey, sell, lease, transfer or other
dispose of (collectively, a "Transfer") or permit any of its
Subsidiaries to Transfer, all or any part of its business or property,
other than: (i) Transfers of Inventory in the ordinary course of
business; (ii) Transfers of non-exclusive licenses and similar
arrangements for the use of the property of Borrower or its
Subsidiaries; or (iii) Transfers of worn-out or obsolete Equipment.
7.2 Change in Business. Borrower will not, without the
prior written consent of Bank which consent shall not be unreasonably
withheld, suffer to occur a Change in Control or engage in any
business, or permit any of its Subsidiaries to engage in any business,
other than the businesses currently engaged in by Borrower and any
business substantially similar or related thereto (or incidental
thereto). Borrower will not, without thirty (30) days prior written
notification to Bank, relocate its chief executive office or change its
name or do business under any other name than is set forth on the
signature page hereof.
7.3 Mergers or Acquisitions. Borrower will not, without
the prior written consent of Bank, which consent shall not be
unreasonably withheld, merge or consolidate, or permit any of its
Subsidiaries to merge or consolidate, with or into any other business
organization, or acquire, or permit any of its Subsidiaries to acquire,
all or substantially all of the capital stock or property of another
Person.
7.4 Indebtedness. Create, incur, assume or be or remain
liable with respect to any Indebtedness, or permit any Subsidiary so to
do, other than Permitted Indebtedness and Indebtedness incurred with
the prior written consent of Bank, which consent shall not unreasonably
be withheld.
7.5 Encumbrances. Create, incur, assume or suffer to
exist any Lien with respect to any of its property, or assign or
otherwise convey any right to receive income, including the sale of any
Accounts, or permit any of its Subsidiaries so to do, except for
Permitted Liens.
7.6 Distributions. Pay any dividends or make any other
distribution or payment on account of or in redemption, retirement or
purchase of any capital stock other than any such dividends,
distributions or payments made with the prior written consent of Bank,
which consent shall not be unreasonably withheld.
7.7 Investments. Directly or indirectly acquire or own,
or make any Investment in or to any Person, or permit any of its
Subsidiaries so to do, other than Permitted Investments or Investments
made with the prior written consent of Bank, which consent shall not be
unreasonably withheld.
7.8 Transactions with Affiliates. Directly or indirectly
enter into or permit to exist any material transaction with any
Affiliate of Borrower except for transactions that are in the ordinary
course of Borrower's business, upon fair and reasonable terms that are
no less favorable to Borrower than would be obtained in an arm's length
transaction with a nonaffiliated Person.
7.9 Subordinated Debt. Make any payment in respect of
any Subordinated Debt, or permit any of its Subsidiaries to make any
such payment, except in compliance with the terms of such Subordinated
Debt, or amend any provision contained in any documentation relating to
the Subordinated Debt without Bank's prior written consent.
7.10 Inventory. Store the Inventory with a bailee,
warehouseman, or similar party unless Bank has received a pledge of the
warehouse receipt covering such Inventory. Except for Inventory sold
in the ordinary course of business and except for such other locations
as Bank may approve in writing, Borrower shall keep the Inventory only
at the location set forth in Section 10 hereof and such other locations
of which Borrower gives Bank prior written notice and as to which
Borrower signs and files a financing statement where needed to perfect
Bank's security interest.
7.11 Compliance. Become an "investment company"
controlled by an "investment company," within the meaning of the
Investment Company Act of 1940, or become principally engaged in, or
undertake as one of its important activities, the business of extending
credit for the purpose of purchasing or carrying margin stock, or use
the proceeds of any Advance for such purpose. Fail to meet the minimum
funding requirements of ERISA, permit a Reportable Event or Prohibited
Transaction, as defined in ERISA, to occur, fail to comply with the
Federal Fair Labor Standards Act or violate any law or regulation,
which violation could have a Material Adverse Effect or a material
adverse effect on the Collateral or the priority of Bank's Lien on the
Collateral, or permit any of its Subsidiaries to do any of the
foregoing.
8. EVENTS OF DEFAULT
Any one or more of the following events shall constitute an Event
of Default by Borrower under this Agreement:
8.1 Payment Default. If Borrower fails to pay the
principal of, or any interest on, any Advances when due and payable; or
fails to pay any portion of any other Obligations not constituting such
principal or interest, including without limitation Bank Expenses.
8.2 Covenant Default.
(a) If Borrower fails to perform any obligation
under Sections 6.7, 6.8, 6.9 or 6.10 or violates any of the covenants
contained in Section 7 of this Agreement, or
(b) If Borrower fails or neglects to perform, keep,
or observe any other material term, provision, condition, covenant, or
agreement contained in this Agreement, in any of the Loan Documents, or
in any other present or future agreement between Borrower and Bank and
as to any default under such other term, provision, condition, covenant
or agreement that can be cured, has failed to cure such default within
ten (10) days after Borrower receives notice thereof or any officer of
Borrower becomes aware thereof; provided, however, that if the default
cannot by its nature be cured within the ten (10) day period or cannot
after diligent attempts by Borrower be cured within such ten (10) day
period, and such default is likely to be cured within a reasonable
time, then Borrower shall have an additional reasonable period (which
shall not in any case exceed thirty (30) days) to attempt to cure such
default, and within such reasonable time period the failure to have
cured such default shall not be deemed an Event of Default (provided
that no Advances will be required to be made during such cure period);
8.3 Material Adverse Change. If there occurs a Material
Adverse Change, or if there is a material impairment of the prospect of
repayment of any portion of the Obligations or a material impairment of
the value or priority of Bank's security interests in the Collateral;
8.4 Attachment. If any material portion of Borrower's
assets is attached, seized, subjected to a writ or distress warrant, or
is levied upon, or comes into the possession of any trustee, receiver
or person acting in a similar capacity and such attachment, seizure,
writ or distress warrant or levy has not been removed, discharged or
rescinded within ten (10) days, or if Borrower is enjoined, restrained,
or in any way prevented by court order from continuing to conduct all
or any material part of its business affairs, or if a judgment or other
claim becomes a lien or encumbrance upon any material portion of
Borrower's assets, or if a notice of lien, levy, or assessment is filed
of record with respect to any of Borrower's assets by the United States
Government, or any department, agency, or instrumentality thereof, or
by any state, county, municipal, or governmental agency, and the same
is not paid within ten (10) days after Borrower receives notice
thereof, provided that none of the foregoing shall constitute an Event
of Default where such action or event is stayed or an adequate bond has
been posted pending a good faith contest by Borrower (provided that no
Advances will be required to be made during such cure period);
8.5 Insolvency. If Borrower becomes insolvent, or if an
Insolvency Proceeding is commenced by Borrower, or if an Insolvency
Proceeding is commenced against Borrower and is not dismissed or stayed
within ten (10) days (provided that no Advances will be made prior to
the dismissal of such Insolvency Proceeding);
8.6 Other Agreements. If there is a default in any
agreement to which Borrower is a party with a third party or parties
resulting in a right by such third party or parties, whether or not
exercised, to accelerate the maturity of any Indebtedness in an amount
in excess of One Hundred Thousand Dollars ($100,000) or that could have
a Material Adverse Effect;
8.7 Subordinated Debt. If Borrower makes any payment on
account of Subordinated Debt, except to the extent such payment is
allowed under any subordination agreement entered into with Bank;
8.8 Judgments. If a judgment or judgments for the
payment of money in an amount, individually or in the aggregate, of at
least Fifty Thousand Dollars ($50,000) shall be rendered against
Borrower and shall remain unsatisfied and unstayed for a period of ten
(10) days (provided that no Advances will be made prior to the
satisfaction or stay of such judgment); or
8.9 Misrepresentations. If any material
misrepresentation or material misstatement exists now or hereafter in
any warranty or representation set forth herein or in any certificate
delivered to Bank by any Responsible Officer pursuant to this Agreement
or to induce Bank to enter into this Agreement or any other Loan
Document.
9. BANK'S RIGHTS AND REMEDIES
9.1 Rights and Remedies. Upon the occurrence and during
the continuance of an Event of Default, Bank may, at its election,
without notice of its election and without demand, do any one or more
of the following, all of which are authorized by Borrower:
(a) Declare all Obligations, whether evidenced by
this Agreement, by any of the other Loan Documents, or otherwise,
immediately due and payable (provided that upon the occurrence of an
Event of Default described in Section 8.5 all Obligations shall become
immediately due and payable without any action by Bank);
(b) Cease advancing money or extending credit to or
for the benefit of Borrower under this Agreement or under any other
agreement between Borrower and Bank;
(c) Settle or adjust disputes and claims directly
with account debtors for amounts, upon terms and in whatever order that
Bank reasonably considers advisable;
(d) Without notice to or demand upon Borrower, make
such payments and do such acts as Bank considers necessary or
reasonable to protect its security interest in the Collateral.
Borrower agrees to assemble the Collateral if Bank so requires, and to
make the Collateral available to Bank as Bank may designate. Borrower
authorizes Bank to enter the premises where the Collateral is located,
to take and maintain possession of the Collateral, or any part of it,
and to pay, purchase, contest, or compromise any encumbrance, charge,
or lien which in Bank's determination appears to be prior or superior
to its security interest and to pay all expenses incurred in connection
therewith. With respect to any of Borrower's owned premises, Borrower
hereby grants Bank a license to enter into possession of such premises
and to occupy the same, without charge, for up to one hundred twenty
(120) days in order to exercise any of Bank's rights or remedies
provided herein, at law, in equity, or otherwise;
(e) Without notice to Borrower set off and apply to
the Obligations any and all (i) balances and deposits of Borrower held
by Bank, or (ii) indebtedness at any time owing to or for the credit or
the account of Borrower held by Bank;
(f) Ship, reclaim, recover, store, finish,
maintain, repair, prepare for sale, advertise for sale, and sell (in
the manner provided for herein) the Collateral. Bank is hereby granted
a license or other right, solely pursuant to the provisions of this
Section 9.1, to use, without charge, Borrower's labels, patents,
copyrights, rights of use of any name, trade secrets, trade names,
trademarks, service marks, and advertising matter, or any property of a
similar nature, as it pertains to the Collateral, in completing
production of, advertising for sale, and selling any Collateral and, in
connection with Bank's exercise of its rights under this Section 9.1,
Borrower's rights under all licenses and all franchise agreements shall
inure to Bank's benefit;
(g) Sell the Collateral at either a public or
private sale, or both, by way of one or more contracts or transactions,
for cash or on terms, in such manner and at such places (including
Borrower's premises) as Bank determines is commercially reasonable;
(h) Bank may credit bid and purchase at any public
sale; and
(i) Any deficiency that exists after disposition of
the Collateral as provided above will be paid immediately by Borrower.
9.2 Power of Attorney. Effective only upon the occurrence
and during the continuance of an Event of Default, Borrower hereby
irrevocably appoints Bank (and any of Bank's designated officers, or
employees) as Borrower's true and lawful attorney to: (a) send requests
for verification of Accounts or notify account debtors of Bank's
security interest in the Accounts; (b) endorse Borrower's name on any
checks or other forms of payment or security that may come into Bank's
possession; (c) sign Borrower's name on any invoice or bill of lading
relating to any Account, drafts against account debtors, schedules and
assignments of Accounts, verifications of Accounts, and notices to
account debtors; (d) make, settle, and adjust all claims under and
decisions with respect to Borrower's policies of insurance; and (e)
settle and adjust disputes and claims respecting the accounts directly
with account debtors, for amounts and upon terms which Bank determines
to be reasonable; provided Bank may exercise such power of attorney to
sign the name of Borrower on any of the documents described in
Section 4.2 regardless of whether an Event of Default has occurred.
The appointment of Bank as Borrower's attorney in fact, and each and
every one of Bank's rights and powers, being coupled with an interest,
is irrevocable until all of the Obligations have been fully repaid and
performed and Bank's obligation to provide Advances hereunder is
terminated.
9.3 Accounts Collection. At any time from the date of
this Agreement, Bank may notify any Person owing funds to Borrower of
Bank's security interest in such funds and verify the amount of such
Account. Borrower shall collect all amounts owing to Borrower for
Bank, receive in trust all payments as Bank's trustee, and immediately
deliver such payments to Bank in their original form as received from
the account debtor, with proper endorsements for deposit.
9.4 Bank Expenses. If Borrower fails to pay any amounts
or furnish any required proof of payment due to third persons or
entities, as required under the terms of this Agreement, then Bank may
do any or all of the following: (a) make payment of the same or any
part thereof; (b) set up such reserves under the Revolving Facility as
Bank deems necessary to protect Bank from the exposure created by such
failure; or (c) obtain and maintain insurance policies of the type
discussed in Section 6.6 of this Agreement, and take any action with
respect to such policies as Bank deems prudent. Any amounts so paid or
deposited by Bank shall constitute Bank Expenses, shall be immediately
due and payable, and shall bear interest at the then applicable rate
hereinabove provided, and shall be secured by the Collateral. Any
payments made by Bank shall not constitute an agreement by Bank to make
similar payments in the future or a waiver by Bank of any Event of
Default under this Agreement.
9.5 Bank's Liability for Collateral. So long as Bank
complies with reasonable banking practices, Bank shall not in any way
or manner be liable or responsible for: (a) the safekeeping of the
Collateral; (b) any loss or damage thereto occurring or arising in any
manner or fashion from any cause; (c) any diminution in the value
thereof; or (d) any act or default of any carrier, warehouseman,
bailee, forwarding agency, or other person whomsoever. All risk of
loss, damage or destruction of the Collateral shall be borne by
Borrower.
9.6 Remedies Cumulative. Bank's rights and remedies
under this Agreement, the Loan Documents, and all other agreements
shall be cumulative. Bank shall have all other rights and remedies not
inconsistent herewith as provided under the Code, by law, or in equity.
No exercise by Bank of one right or remedy shall be deemed an election,
and no waiver by Bank of any Event of Default on Borrower's part shall
be deemed a continuing waiver. No delay by Bank shall constitute a
waiver, election, or acquiescence by it. No waiver by Bank shall be
effective unless made in a written document signed on behalf of Bank
and then shall be effective only in the specific instance and for the
specific purpose for which it was given.
9.7 Demand; Protest. Express for the notice requirements
expressly set forth herein, Borrower waives demand, protest, notice of
protest, notice of default or dishonor, notice of payment and
nonpayment, notice of any default, nonpayment at maturity, release,
compromise, settlement, extension, or renewal of accounts, documents,
instruments, chattel paper, and guarantees at any time held by Bank on
which Borrower may in any way be liable.
10. NOTICES
Unless otherwise provided in this Agreement, all notices or
demands by any party relating to this Agreement or any other agreement
entered into in connection herewith shall be in writing and (except for
financial statements and other informational documents which may be
sent by first-class mail, postage prepaid) shall be personally
delivered or sent by a recognized overnight delivery service, certified
mail, postage prepaid, return receipt requested, or by
telefacsimile to Borrower or to Bank, as the case may be, at its
addresses set forth below:
If to Borrower Consilium, Inc.
485 Clyde Avenue
Mountain View, CA 94043
Attn: Clifton Wong
Fax: 650/691-6350
If to Bank Venture Banking Group
Three Palo Alto Square, Suite 150
Palo Alto, CA 94306
Attn: Jon Krogstad
Fax: 650/843-6969
The parties hereto may change the address at which they are to
receive notices hereunder, by notice in writing in the foregoing manner
given to the other.
11. CHOICE OF LAW AND VENUE; JURY TRIAL WAIVER
This Agreement shall be governed by, and construed in accordance
with, the internal laws of the State of California, without regard to
principles of conflicts of law. Each of Borrower and Bank hereby
submits to the exclusive jurisdiction of the state and Federal courts
located in the County of Santa Clara, State of California. BORROWER
AND BANK EACH HEREBY WAIVE THEIR RESPECTIVE RIGHTS TO A JURY TRIAL OF
ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF ANY OF THE
LOAN DOCUMENTS OR ANY OF THE TRANSACTIONS CONTEMPLATED THEREIN,
INCLUDING CONTRACT CLAIMS, TORT CLAIMS, BREACH OF DUTY CLAIMS, AND ALL
OTHER COMMON LAW OR STATUTORY CLAIMS. EACH PARTY RECOGNIZES AND AGREES
THAT THE FOREGOING WAIVER CONSTITUTES A MATERIAL INDUCEMENT FOR IT TO
ENTER INTO THIS AGREEMENT. EACH PARTY REPRESENTS AND WARRANTS THAT IT
HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL AND THAT IT KNOWINGLY
AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION
WITH LEGAL COUNSEL.
12. GENERAL PROVISIONS
12.1 Successors and Assigns. This Agreement shall bind
and inure to the benefit of the respective successors and permitted
assigns of each of the parties; provided, however, that neither this
Agreement nor any rights hereunder may be assigned by Borrower without
Bank's prior written consent, which consent may be granted or withheld
in Bank's sole discretion. Bank shall have the right without the
consent of or notice to Borrower to sell, transfer, negotiate, or grant
participation in all or any part of, or any interest in, Bank's
obligations, rights and benefits hereunder.
12.2 Indemnification. Borrower shall defend, indemnify
and hold harmless Bank and its officers, employees, and agents against:
(a) all obligations, demands, claims, and liabilities claimed or
asserted by any other party in connection with the transactions
contemplated by this Agreement; and (b) all losses or Bank Expenses in
any way suffered, incurred, or paid by Bank as a result of or in any
way arising out of, following, or consequential to transactions between
Bank and Borrower whether under this Agreement, or otherwise (including
without limitation reasonable attorneys fees and expenses), except for
losses caused by Bank's gross negligence or willful misconduct.
12.3 Time of Essence. Time is of the essence for the
performance of all obligations set forth in this Agreement.
12.4 Severability of Provisions. Each provision of this
Agreement shall be severable from every other provision of this
Agreement for the purpose of determining the legal enforceability of
any specific provision.
12.5 Amendments in Writing, Integration. This Agreement
cannot be amended or terminated orally. All prior agreements,
understandings, representations, warranties, and negotiations between
the parties hereto with respect to the subject matter of this
Agreement, if any, are merged into this Agreement and the Loan
Documents.
12.6 Counterparts. This Agreement may be executed in any
number of counterparts and by different parties on separate
counterparts, each of which, when executed and delivered, shall be
deemed to be an original, and all of which, when taken together, shall
constitute but one and the same Agreement.
12.7 Survival. All covenants, representations and
warranties made in this Agreement shall continue in full force and
effect so long as any Obligations remain outstanding. The obligations
of Borrower to indemnify Bank with respect to the expenses, damages,
losses, costs and liabilities described in Section 12.2 shall survive
until all applicable statute of limitations periods with respect to
actions that may be brought against Bank have run.
12.8 Confidentiality. In handling any confidential
information of Borrower or any Subsidiary, Bank shall exercise the same
degree of care that it exercises with respect to its own proprietary
information of the same types to maintain the confidentiality of any
non-public information thereby received or received pursuant to this
Agreement except that disclosure of such information may be made (i) to
the subsidiaries or Affiliates of Bank in connection with their present
or prospective business relations with Borrower, (ii) as required by
law, regulations, rule or order, subpoena, judicial order or similar
order and (iii) as may be required in connection with the examination,
audit or similar investigation of Bank. Confidential information
hereunder shall not include information that either: (a) is in the
public domain or in the knowledge or possession of Bank when disclosed
to Bank, or becomes part of the public domain after disclosure to Bank
through no fault of Bank; or (b) is disclosed to Bank by a third party,
provided Bank does not have actual knowledge that such third party is
prohibited from disclosing such information.
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to
be executed as of the date first above written.
VENTURE BANKING GROUP CONSILIUM, INC.
By: By:
Title: Title:
<PAGE>
EXHIBIT A
The Collateral shall consist of all right, title and interest of
Borrower in and to the following:
(a) All goods and equipment now owned or hereafter
acquired, including, without limitation, all machinery, fixtures,
vehicles (including motor vehicles and trailers), and any interest in
any of the foregoing, and all attachments, accessories, accessions,
replacements, substitutions, additions, and improvements to any of the
foregoing, wherever located;
(b) All inventory, now owned or hereafter acquired,
including, without limitation, all merchandise, raw materials, parts,
supplies, packing and shipping materials, work in process and finished
products including such inventory as is temporarily out of Borrower's
custody or possession or in transit and including any returns upon any
accounts or other proceeds, including insurance proceeds, resulting
from the sale or disposition of any of the foregoing and any documents
of title representing any of the above, and Borrower's Books relating
to any of the foregoing;
(c) All contract rights and general intangibles now
owned or hereafter acquired, including, without limitation, goodwill,
trademarks, servicemarks, trade styles, trade names, patents, patent
applications, leases, license agreements, franchise agreements,
blueprints, drawings, purchase orders, customer lists, route lists,
infringements, claims, computer programs, computer discs, computer
tapes, literature, reports, catalogs, design rights, income tax
refunds, payments of insurance and rights to payment of any kind;
(d) All now existing and hereafter arising
accounts, contract rights, royalties, license rights and all other
forms of obligations owing to Borrower arising out of the sale or lease
of goods, the licensing of technology or the rendering of services by
Borrower, whether or not earned by performance, and any and all credit
insurance, guaranties, and other security therefor, as well as all
merchandise returned to or reclaimed by Borrower and Borrower's Books
relating to any of the foregoing;
(e) All documents, cash, deposit accounts,
securities, investment property, letters of credit, certificates of
deposit, instruments and chattel paper now owned or hereafter acquired
and Borrower's Books relating to the foregoing;
(f) All copyright rights, copyright applications,
copyright registrations and like protections in each work of authorship
and derivative work thereof, whether published or unpublished, now
owned or hereafter acquired; all trade secret rights, including all
rights to unpatented inventions, know-how, operating manuals, license
rights and agreements and confidential information, now owned or
hereafter acquired; all mask work or similar rights available for the
protection of semiconductor chips, now owned or hereafter acquired; all
claims for damages by way of any past, present and future infringement
of any of the foregoing; and
(g) Any and all claims, rights and interests in any
of the above and all substitutions for, additions and accessions to and
proceeds thereof.
<PAGE>
EXHIBIT B
LOAN PAYMENT/ADVANCE TELEPHONE REQUEST FORM
DEADLINE FOR SAME DAY PROCESSING IS 3:00 P.M., P.S.T.
TO: VENTURE LENDING DATE:
FAX#: (650) 843-6969 TIME:
FROM: CONSILIUM, INC.
REQUESTED BY:
AUTHORIZED SIGNER'S NAME
AUTHORIZED SIGNATURE:
PHONE NUMBER:
FROM ACCOUNT # TO ACCOUNT #
REQUESTED TRANSACTION TYPE REQUEST DOLLAR AMOUNT
PRINCIPAL INCREASE (ADVANCE) $
PRINCIPAL PAYMENT (ONLY) $
INTEREST PAYMENT (ONLY) $
PRINCIPAL AND INTEREST (PAYMENT) $
OTHER INSTRUCTIONS:
All representations and warranties of Borrower stated in the Loan
Agreement are true, correct and complete in all material respects as of
the date of the telephone request for and Advance confirmed by this
Borrowing Certificate; provided, however, that those representations
and warranties expressly referring to another date shall be true,
correct and complete in all material respects as of such date.
BANK USE ONLY
TELEPHONE REQUEST:
The following person is authorized to request the loan payment
transfer/loan advance on the advance designated account and is known to
me.
Phone #:
AUTHORIZED REQUESTER
Phone #:
RECEIVED BY (BANK)
AUTHORIZED SIGNATURE (BANK)
<PAGE>
EXHIBIT C
BORROWING BASE CERTIFICATE
Borrower: CONSILIUM, INC. Bank: Venture Banking Group
Commitment Amount: $3,750,000
ACCOUNTS RECEIVABLE
1. Accounts Receivable Book Value as of $
2. Additions (please explain on reverse) $
3. TOTAL ACCOUNTS RECEIVABLE $
ACCOUNTS RECEIVABLE DEDUCTIONS (without duplication)
4. Amounts over 90 days from invoice $
5. Eligible Foreign Accounts over 120 days from invoice $
6. Balance of 25% over 90 day accounts $
7. Concentration Limits $
8. Foreign Accounts $
9. Governmental Accounts $
10. Contra Accounts $
11. Promotion or Demo Accounts $
12. Intercompany/Employee Accounts $
13. Amount by which loan value of German/Taiwan
subsidiary accounts exceeds $750,000 $
14. Other (please explain on reverse) $
15. TOTAL ACCOUNTS RECEIVABLE DEDUCTIONS $
16. Eligible Accounts (#3 minus #15) $
17. LOAN VALUE OF ACCOUNTS (80 % of #16) $
BALANCES
18. Maximum Loan Amount $
19. Total Funds Available (#17) $
20. Present balance owing on Line of Credit $
The undersigned represents and warrants that the foregoing is true,
complete and correct, and that the information reflected in this
Borrowing Base Certificate complies with the representations and
warranties set forth in the Loan and Security Agreement between the
undersigned and Venture Banking Group.
COMMENTS:
By:
Authorized Signer
<PAGE>
EXHIBIT D
COMPLIANCE CERTIFICATE
TO: VENTURE BANKING GROUP
FROM: CONSILIUM, INC.
The undersigned authorized officer of Consilium, Inc. hereby
certifies that in accordance with the terms and conditions of the Loan
and Security Agreement between Borrower and Bank (the "Agreement"), (i)
Borrower is in complete compliance for the period ending
with all required covenants except as noted below and (ii) all
representations and warranties of Borrower stated in the Agreement are
true and correct in all material respects as of the date hereof.
Attached herewith are the required documents supporting the above
certification. The Officer further certifies that these are prepared
in accordance with Generally Accepted Accounting Principles (GAAP) and
are consistently applied from one period to the next except as
explained in an accompanying letter or footnotes.
Please indicate compliance status by circling Yes/No under "Complies"
column.
Reporting Covenant Required Complies
Monthly financial statements Monthly within 20 days Yes No
Annual (CPA Audited) FYE within 90 days Yes No
A/R & A/P Agings Monthly within 20 days Yes No
A/R Audit Initial and Semi-Annual Yes No
Financial Covenant Required Actual Complies
Maintain on a Monthly Basis:
Minimum Tangible Net Worth $2,500,000 $_____ Yes No
Maximum Debt/Tangible Net Worth 3.50:1.0 _____:1.0 Yes No
One of the following:
Minimum Debt Services Ratio 1.25:1.0 _____:1.0 Yes No
Minimum Cash Ratio 1.75:1.0 _____:1.0 Yes No
Comments Regarding Exceptions: See Attached.
Sincerely,
SIGNATURE
TITLE
DATE
<PAGE>
EXHIBIT E
Revolving Facility Promissory Note
$3,750,000 Palo Alto, California
July ___, 1998
FOR VALUE RECEIVED, the undersigned, Consilium, Inc., a Delaware
corporation (the "Borrower"), promises to pay to the order of Venture
Banking Group, a division of Cupertino National Bank ("Bank"), at such
place as the holder hereof may designate, in lawful money of the United
States of America, the aggregate unpaid principal amount of all
Advances made by Bank to Borrower under Section 2.1 of that certain
Loan and Security Agreement between Borrower and Bank of even date
herewith, as amended from time to time (the "Loan Agreement"), up to a
maximum principal amount of Three Million Seven Hundred Fifty Thousand
Dollars ($3,750,000). Borrower shall also pay interest on the
aggregate unpaid principal amount of such Advances at the rates and in
accordance with the terms of the Loan Agreement. The entire principal
amount and all accrued but unpaid interest thereon shall be due and
payable on the Revolving Facility Maturity Date. All capitalized terms
used herein but not defined herein shall have the same meaning as given
to them in the Loan Agreement.
Bank is hereby authorized by Borrower to endorse on Bank's books and
records each Advance made by Bank under this Note and the amount of
each payment or prepayment of principal of each such Advance received
by Bank; it being understood, however, that failure to make any such
endorsement (or any errors in notation) shall not affect the
obligations of Borrower with respect to Advances made hereunder, and
payments of principal by Borrower shall be credited to Borrower
notwithstanding the failure to make a notation (or any errors in
notation) thereof on such books and records.
Borrower promises to pay Bank all costs and expenses of collection of
this Note and to pay all reasonable attorneys' fees incurred in such
collection or in any suit or action to collect this Note or in any
appeal thereof. Borrower waives presentment, demand, protest, notice
of protest, notice of dishonor, notice of nonpayment, and any and all
other notices and demands in connection with the delivery, acceptance,
performance, default or enforcement of this Note, as well as any
applicable statute of limitations. No delay by Bank in exercising any
power or right hereunder shall operate as a waiver of any power or
right. Time is of the essence as to all obligations hereunder.
This Note is issued pursuant to the Loan Agreement, which shall govern
the rights and obligations of Borrower with respect to all obligations
hereunder.
BORROWER AND BANK HEREBY WAIVE THEIR RIGHTS TO A JURY TRIAL OF ANY
CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS NOTE,
INCLUDING CONTRACT CLAIMS, TORT CLAIMS, BREACH OF DUTY CLAIMS, AND ALL
OTHER COMMON LAW OR STATUTORY CLAIMS. This Note shall be deemed to be
made under, and shall be construed in accordance with and governed by
the laws of the State of California, excluding conflicts of laws
principles.
CONSILIUM, INC.
By:
Printed Name:
Title:
<PAGE>
EXHIBIT F
Term Loan Promissory Note
$2,750,000 Palo Alto, California
July ___, 1998
FOR VALUE RECEIVED, the undersigned, Consilium, Inc., a Delaware
corporation (the "Borrower"), promises to pay to the order of Venture
Banking Group, a division of Cupertino National Bank ("Bank"), at such
place as the holder hereof may designate, in lawful money of the United
States of America, the aggregate unpaid principal amount of the Term
Loan made by Bank to Borrower under Section 2.2 of that certain Loan
and Security Agreement between Borrower and Bank of even date herewith,
as amended from time to time (the "Loan Agreement"), up to a maximum
principal amount of Two Million Seven Hundred Fifty Thousand Dollars
($2,750,000). Borrower shall pay installments of principal and
interest with respect to the Term Loan in accordance with the terms of
the Loan Agreement. The remaining principal amount and all accrued but
unpaid interest thereon shall be due and payable on the Term Loan
Maturity Date. All capitalized terms used herein but not defined
herein shall have the same meaning as given to them in the Loan
Agreement.
Bank is hereby authorized by Borrower to endorse on Bank's books and
records each advance made by Bank under this Note and the amount of
each payment or prepayment of principal of each such advance received
by Bank; it being understood, however, that failure to make any such
endorsement (or any errors in notation) shall not affect the
obligations of Borrower with respect to advances made hereunder, and
payments of principal by Borrower shall be credited to Borrower
notwithstanding the failure to make a notation (or any errors in
notation) thereof on such books and records.
Borrower promises to pay Bank all costs and expenses of collection of
this Note and to pay all reasonable attorneys' fees incurred in such
collection or in any suit or action to collect this Note or in any
appeal thereof. Borrower waives presentment, demand, protest, notice
of protest, notice of dishonor, notice of nonpayment, and any and all
other notices and demands in connection with the delivery, acceptance,
performance, default or enforcement of this Note, as well as any
applicable statute of limitations. No delay by Bank in exercising any
power or right hereunder shall operate as a waiver of any power or
right. Time is of the essence as to all obligations hereunder.
This Note is issued pursuant to the Loan Agreement, which shall govern
the rights and obligations of Borrower with respect to all obligations
hereunder.
BORROWER AND BANK HEREBY WAIVE THEIR RIGHTS TO A JURY TRIAL OF ANY
CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS NOTE,
INCLUDING CONTRACT CLAIMS, TORT CLAIMS, BREACH OF DUTY CLAIMS, AND ALL
OTHER COMMON LAW OR STATUTORY CLAIMS. This Note shall be deemed to be
made under, and shall be construed in accordance with and governed by
the laws of the State of California, excluding conflicts of laws
principles.
CONSILIUM, INC.
By:
Printed Name:
Title:
<PAGE>
Revolving Facility Promissory Note
$3,750,000 Palo Alto, California
July 24, 1998
FOR VALUE RECEIVED, the undersigned, Consilium, Inc., a Delaware
corporation (the "Borrower"), promises to pay to the order of Venture
Banking Group, a division of Cupertino National Bank ("Bank"), at such
place as the holder hereof may designate, in lawful money of the United
States of America, the aggregate unpaid principal amount of all
Advances made by Bank to Borrower under Section 2.1 of that certain
Loan and Security Agreement between Borrower and Bank of even date
herewith, as amended from time to time (the "Loan Agreement"), up to a
maximum principal amount of Three Million Seven Hundred Fifty Thousand
Dollars ($3,750,000). Borrower shall also pay interest on the
aggregate unpaid principal amount of such Advances at the rates and in
accordance with the terms of the Loan Agreement. The entire principal
amount and all accrued but unpaid interest thereon shall be due and
payable on the Revolving Facility Maturity Date. All capitalized terms
used herein but not defined herein shall have the same meaning as given
to them in the Loan Agreement.
Bank is hereby authorized by Borrower to endorse on Bank's books and
records each Advance made by Bank under this Note and the amount of
each payment or prepayment of principal of each such Advance received
by Bank; it being understood, however, that failure to make any such
endorsement (or any errors in notation) shall not affect the
obligations of Borrower with respect to Advances made hereunder, and
payments of principal by Borrower shall be credited to Borrower
notwithstanding the failure to make a notation (or any errors in
notation) thereof on such books and records.
Borrower promises to pay Bank all costs and expenses of collection of
this Note and to pay all reasonable attorneys' fees incurred in such
collection or in any suit or action to collect this Note or in any
appeal thereof. Borrower waives presentment, demand, protest, notice
of protest, notice of dishonor, notice of nonpayment, and any and all
other notices and demands in connection with the delivery, acceptance,
performance, default or enforcement of this Note, as well as any
applicable statute of limitations. No delay by Bank in exercising any
power or right hereunder shall operate as a waiver of any power or
right. Time is of the essence as to all obligations hereunder.
This Note is issued pursuant to the Loan Agreement, which shall govern
the rights and obligations of Borrower with respect to all obligations
hereunder.
BORROWER AND BANK HEREBY WAIVE THEIR RIGHTS TO A JURY TRIAL OF ANY
CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS NOTE,
INCLUDING CONTRACT CLAIMS, TORT CLAIMS, BREACH OF DUTY CLAIMS, AND ALL
OTHER COMMON LAW OR STATUTORY CLAIMS. This Note shall be deemed to be
made under, and shall be construed in accordance with and governed by
the laws of the State of California, excluding conflicts of laws
principles.
CONSILIUM, INC.
By:
Printed Name:
Title:
<PAGE>
Term Loan Promissory Note
$2,750,000 Palo Alto, California
July 24, 1998
FOR VALUE RECEIVED, the undersigned, Consilium, Inc., a Delaware
corporation (the "Borrower"), promises to pay to the order of Venture
Banking Group, a division of Cupertino National Bank ("Bank"), at such
place as the holder hereof may designate, in lawful money of the United
States of America, the aggregate unpaid principal amount of the Term
Loan made by Bank to Borrower under Section 2.2 of that certain Loan
and Security Agreement between Borrower and Bank of even date herewith,
as amended from time to time (the "Loan Agreement"), up to a maximum
principal amount of Two Million Seven Hundred Fifty Thousand Dollars
($2,750,000). Borrower shall pay installments of principal and
interest with respect to the Term Loan in accordance with the terms of
the Loan Agreement. The remaining principal amount and all accrued but
unpaid interest thereon shall be due and payable on the Term Loan
Maturity Date. All capitalized terms used herein but not defined
herein shall have the same meaning as given to them in the Loan
Agreement.
Bank is hereby authorized by Borrower to endorse on Bank's books and
records each advance made by Bank under this Note and the amount of
each payment or prepayment of principal of each such advance received
by Bank; it being understood, however, that failure to make any such
endorsement (or any errors in notation) shall not affect the
obligations of Borrower with respect to advances made hereunder, and
payments of principal by Borrower shall be credited to Borrower
notwithstanding the failure to make a notation (or any errors in
notation) thereof on such books and records.
Borrower promises to pay Bank all costs and expenses of collection of
this Note and to pay all reasonable attorneys' fees incurred in such
collection or in any suit or action to collect this Note or in any
appeal thereof. Borrower waives presentment, demand, protest, notice
of protest, notice of dishonor, notice of nonpayment, and any and all
other notices and demands in connection with the delivery, acceptance,
performance, default or enforcement of this Note, as well as any
applicable statute of limitations. No delay by Bank in exercising any
power or right hereunder shall operate as a waiver of any power or
right. Time is of the essence as to all obligations hereunder.
This Note is issued pursuant to the Loan Agreement, which shall govern
the rights and obligations of Borrower with respect to all obligations
hereunder.
BORROWER AND BANK HEREBY WAIVE THEIR RIGHTS TO A JURY TRIAL OF ANY
CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS NOTE,
INCLUDING CONTRACT CLAIMS, TORT CLAIMS, BREACH OF DUTY CLAIMS, AND ALL
OTHER COMMON LAW OR STATUTORY CLAIMS. This Note shall be deemed to be
made under, and shall be construed in accordance with and governed by
the laws of the State of California, excluding conflicts of laws
principles.
CONSILIUM, INC.
By:
Printed Name:
Title:
<PAGE>
COLLATERAL ASSIGNMENT, PATENT MORTGAGE
AND SECURITY AGREEMENT
THIS COLLATERAL ASSIGNMENT, PATENT MORTGAGE AND SECURITY AGREEMENT is
made as of the 24th day of July 1998, by and between CONSILIUM, INC.
("Assignor") a Delaware corporation, and VENTURE BANKING GROUP, a division of
Cupertino National Bank ("Assignee").
RECITALS
A. Assignee has agreed to lend to Assignor certain funds (the
"Loan") and Assignor desires to borrow such funds from Assignee pursuant
to the terms of that certain Loan and Security Agreement dated even date
herewith (the "Loan Agreement"). The Loan is evidenced by one or more
promissory notes (a "Note" or, collectively, the "Notes").
B. In order to induce Assignee to make the Loan, Assignor has
agreed to assign certain intangible property to Assignee for purposes of
securing the obligations of Assignor to Assignee.
C. Unless otherwise defined herein, all capitalized terms shall
have the meanings ascribed to them in the Loan Agreement.
NOW, THEREFORE, THE PARTIES HERETO AGREE AS FOLLOWS:
1. Assignment, Patent Mortgage and Grant of Security Interest. As
collateral security for the prompt and complete payment and performance
of all of Assignor's present or future indebtedness, obligations and
liabilities to Assignee, Assignor hereby assigns, transfers, conveys
and grants a security interest and mortgage to Assignee, as security,
but not as an ownership interest in and to Assignor's entire right,
title and interest in, to and under the following (all of which shall
collectively be called the "Collateral"):
1.1 Any and all copyright rights, copyright applications,
copyright registrations and like protections in each work or authorship
and derivative work thereof, whether published or unpublished and
whether or not the same also constitutes a trade secret, now or
hereafter existing, created, acquired or held, including without
limitation those set forth on Exhibit A attached hereto (collectively,
the "Copyrights");
1.2 Any and all trade secrets, and any and all intellectual
property rights in computer software and computer software products now
or hereafter existing, created, acquired or held;
1.3 Any and all design rights which may be available to
Assignor now or hereafter existing, created, acquired or held;
1.4 All patents, patent applications and like protections
including, without limitation, improvements, divisions, continuations,
renewals, reissues, extensions and continuations-in-part of the same,
including without limitation the patents and patent applications set
forth on Exhibit B attached hereto (collectively, the "Patents");
1.5 Any trademark and servicemark rights, whether registered or
not, applications to register and registrations of the same and like
protections, and the entire goodwill of the business of Assignor
connected with and symbolized by such trademarks, including without
limitation those set forth on Exhibit C attached hereto (collectively,
the "Trademarks");
1.6 Any and all claims for damages by way of past, present and
future infringements of any of the rights included above, with the
right, but not the obligation, to sue for and collect such damages for
said use or infringement of the intellectual property rights identified
above;
1.7 All licenses or other rights to use any of the Copyrights,
Patents or Trademarks, and all license fees and royalties arising from
such use to the extent permitted by such license or rights;
1.8 All amendments, extensions, renewals and extensions of any
of the Copyrights, Trademarks or Patents;
1.9 All proceeds and products of the foregoing, including
without limitation all payments under insurance or any indemnity or
warranty payable in respect of any of the foregoing; and
1.10 The Collateral shall not include Assignor's interest in any
licenses that would be breached by Assignor's grant of a security
interest in its rights thereunder, unless the provision that would
otherwise be breached would be rendered ineffective by Section 9-318 of
the California Uniform Commercial Code.
THE INTEREST IN THE COLLATERAL BEING ASSIGNED HEREUNDER SHALL NOT BE
CONSTRUED AS A CURRENT ASSIGNMENT, BUT AS A CONTINGENT ASSIGNMENT ONLY TO
SECURE ASSIGNOR'S OBLIGATIONS TO ASSIGNEE UNDER THE NOTES AND THE LOAN
AGREEMENT.
2. Authorization and Request. Assignor authorizes and requests that
the Register of Copyrights and the Commissioner of Patents and
Trademarks record this conditional assignment.
3. Covenants and Warranties. Assignor represents, warrants,
covenants and agrees as follows:
3.1 Assignor is now the sole owner of the Collateral, except
for non-exclusive licenses granted by Assignor to its customers in the
ordinary course of business and third party software embedded in the
Collateral;
3.2 Performance of this Assignment does not conflict with or
result in a breach of any agreement to which Assignor is bound other
than the breach of provisions in agreements that would otherwise be
rendered ineffective by Section 9-318 of the California Uniform
Commercial Code;
3.3 During the term of this Agreement, Assignor will not
transfer or otherwise encumber any interest in the Collateral, except
for non-exclusive licenses granted by Assignor in the ordinary course
of business or as set forth in this Assignment;
3.4 To its knowledge, each of the Patents is valid and
enforceable, and no part of the Collateral has been judged invalid or
unenforceable, in whole or in part, and no claim has been made that any
part of the Collateral violates the rights of any third party;
3.5 Assignor shall promptly advise Assignee of any Material
Adverse Change in the composition of the Collateral, including but not
limited to any subsequent ownership right of the Assignor in or to any
Trademark, Patent or Copyright not specified in this Assignment;
3.6 Assignor shall (i) protect, defend and maintain the
validity and enforceability of the Trademarks, Patents and Copyrights,
(ii) use commercially reasonable efforts to detect infringements of the
Trademarks, Patents and Copyrights and promptly advise Assignee in
writing of material infringements detected and (iii) not allow any
Trademarks, Patents, or Copyrights to be abandoned, forfeited or
dedicated to the public without the written consent of Assignee, which
shall not be unreasonably withheld, unless Assignor determines that
reasonable business practices suggest that abandonment is appropriate;
3.7 Assignor shall promptly register the most recent version of
any of Assignor's Copyrights, if not so already registered and if in
keeping with the Assignor's normal business policy, and shall, from
time to time, execute and file such other instruments, and take such
further actions as Assignee may reasonably request from time to time to
perfect or continue the perfection of Assignee's interest in the
Collateral;
3.8 This Assignment creates, and in the case of after acquired
Collateral, this Assignment will create at the time Assignor first has
rights in such after acquired Collateral, in favor of Assignee a valid
and perfected first priority security interest in the Collateral in the
United States securing the payment and performance of the obligations
under the Loan Agreement or evidenced by the Notes upon making the
filings referred to in clause (i) below;
3.9 To its knowledge, except for, and upon, the filing with the
United States Patent and Trademark office with respect to the Patents
and Trademarks and the Register of Copyrights with respect to the
Copyrights necessary to perfect the security interests and assignment
created hereunder and except as has been already made or obtained, no
authorization, approval or other action by, and no notice to or filing
with, any U.S. governmental authority of U.S. regulatory body is
required either (i) for the grant by Assignor of the security interest
granted hereby or for the execution, delivery or performance of this
Assignment by Assignor in the U.S. or (ii) for the perfection in the
United States or the exercise by Assignee of its rights and remedies
thereunder;
3.10 All information heretofore, herein or hereafter supplied to
Assignee by or on behalf of Assignor with respect to the Collateral is
accurate and complete in all material respects;
3.11 Assignor shall not enter into any agreement that would
materially impair or conflict with Assignor's obligations hereunder
without Assignee's prior written consent, which consent shall not be
unreasonably withheld. Assignor shall not permit the inclusion in any
material contract to which it becomes a party of any provisions that
could or might in any way prevent the creation of a security interest
in Assignor's rights and interest in any property included within the
definition of the Collateral acquired under such contracts;
3.12 Upon any executive officer of Assignor obtaining actual
knowledge thereof, Assignor will promptly notify Assignee in writing of
any event that materially adversely affects the value of any
Collateral, the ability of Assignor to dispose of any Collateral or the
rights and remedies of Assignee in relation thereto, including the levy
of any legal process against any of the Collateral.
4. Assignee's Rights. Assignee shall have the right, but not the
obligation, to take, at Assignor's sole expense, any actions that
Assignor is required under this Assignment to take but which Assignor
fails to take, after fifteen (15) days' notice to Assignor. Assignor
shall reimburse and indemnify Assignee for all reasonable costs and
reasonable expenses incurred in the reasonable exercise of its rights
under this Section 4.
5. Inspection Rights. Assignor hereby grants to Assignee and its
employees, representatives and agents the right to visit, during
reasonable hours upon prior reasonable written notice to Assignor, and
any of Assignor's plants and facilities that manufacture, install or
store products (or that have done so during the prior six-month period)
that are sold utilizing any of the Collateral, and to inspect the
products and quality control records relating thereto upon reasonable
written notice to Assignor and as often as may be reasonably requested
(it being understood that any information obtained in such inspection
shall be subject to the confidentiality provisions of Section 16
hereof).
6. Further Assurances; Attorney in Fact.
6.1 On a continuing basis, Assignor will, subject to any prior
licenses, encumbrances and restrictions and prospective licenses, make,
execute, acknowledge and deliver, and file and record in the proper
filing and recording places in the United States, all such instruments,
including, appropriate financing and continuation statements and
collateral agreements and filings with the United States Patent and
Trademarks Office and the Register of Copyrights, and take all such
action as may reasonably be deemed necessary or advisable, or as
requested by Assignee, to perfect Assignee's security interest in all
Copyrights, Patents and Trademarks and otherwise to carry out the
intent and purposes of this Collateral Assignment, or for assuring and
confirming to Assignee the grant or perfection of a security interest
in all Collateral.
6.2 Assignor hereby irrevocably appoints Assignee as Assignor's
attorney-in-fact, with full authority in the place and stead of
Assignor and in the name of Assignor, Assignee or otherwise, from time
to time in Assignee's discretion, upon Assignor's failure or inability
to do so, to take any action and to execute any instrument which
Assignee may deem necessary or advisable to accomplish the purposes of
this Collateral Assignment, including:
(a) To modify, in its sole discretion, this Collateral
Assignment without first obtaining Assignor's approval of or signature
to such modification by amending Exhibit A, Exhibit B and Exhibit C,
thereof, as appropriate, to include reference to any right, title or
interest in any Copyrights, Patents or Trademarks acquired by Assignor
after the execution hereof or to delete any reference to any right,
title or interest in any Copyrights, Patents or Trademarks in which
Assignor no longer has or claims any right, title or interest; and
(b) To file, in its sole discretion, one or more
financing or continuation statements and amendments thereto, relative
to any of the Collateral without the signature of Assignor where
permitted by law.
7. Events of Default. The occurrence of any of the following shall
constitute an Event of Default under the Assignment:
7.1 An Event of Default occurs under the Loan Agreement or any
Note; or
7.2 Assignor breaches any warranty or agreement made by
Assignor in this Assignment other than as set forth in Section 7.3.
7.3 Assignor breaches any warranty or agreement made by
Assignor in Sections 3.5 and 3.12 hereof and any such breach shall not
have been cured to Assignee's satisfaction within ten (10) days after
Assignor shall have first become aware thereof.
8. Remedies. Upon the occurrence and continuance of an Event of
Default, Assignee shall have the right to exercise all the remedies of
a secured party under the California Uniform Commercial Code, including
without limitation the right to require Assignor to assemble the
Collateral and any tangible property in which Assignee has a security
interest and to make it available to Assignee at a place designated by
Assignee. Assignee shall have a nonexclusive, royalty free license to
use the Copyrights, Patents and Trademarks to the extent reasonably
necessary to permit Assignee to exercise its rights and remedies upon
the occurrence of an Event of Default. Assignor will pay any expenses
(including reasonable attorney's fees) incurred by Assignee in
connection with the exercise of any of Assignee's rights hereunder,
including, without limitation, any expense incurred in disposing of the
Collateral. All of Assignee's rights and remedies with respect to the
Collateral shall be cumulative.
9. Indemnity. Assignor agrees to defend, indemnify and hold
harmless Assignee and its officers, employees, and agents against: (a)
all obligations, demands, claims, and liabilities claimed or asserted
by any other party in connection with the transactions contemplated by
this Agreement, and (b) all losses or expenses in any way suffered,
incurred, or paid by Assignee as a result of or in any way arising out
of, following or consequential to transactions between Assignee and
Assignor, whether under this Assignment or otherwise (including without
limitation, reasonable attorneys fees and reasonable expenses), except
for losses arising form or out of Assignee's gross negligence or
willful misconduct.
10. Reassignment. At such time as Assignor shall completely satisfy
all of the obligations secured hereunder, Assignee shall execute and
deliver to Assignor all deed, assignments, and other instruments as may
necessary or proper to reinvest in Assignor full title to the property
assigned hereunder, subject to any disposition thereof which may have
been made by Assignee pursuant hereto.
11. Course of Dealing. No course of dealing, nor any failure to
exercise, nor any delay in exercising any right, power or privilege
hereunder shall operate as a waiver thereof.
12. Attorneys' Fees. If any action relating to this Assignment is
brought by either party hereto against the other party, the prevailing
party shall be entitled to recover reasonable attorneys fees, costs and
disbursements.
13. Amendments. This Assignment may be amended only by a written
instrument signed by both parties hereto.
14. Counterparts. This Assignment may be executed in two or more
counterparts, each of which shall be deemed an original but all of
which together shall constitute the same instrument.
15. California Law and Jurisdiction. This Assignment shall be
governed by the laws of the State of California, without regard for
choice of law provisions. Assignor and Assignee consent to the
nonexclusive jurisdiction of any state or federal court located in
Santa Clara County, California.
16. Confidentiality. In handling any confidential information of
Borrower or any Subisidiary, Assignee shall exercise the same degree of
care that it exercises with respect to its own proprietary information
of the same types to maintain the confidentiality of any non-public
information thereby received or received pursuant to this Assignment
except that the disclosure of this information may be made (i) to the
Affiliates of the Assignee, (ii) as required by law, regulation, rule
or order, subpoena judicial order or similar order and (iii) as may be
required in connection with the examination, audit or similar
investigation of Assignee.
IN WITNESS WHEREOF, the parties hereto have executed this Assignment
on the day and year first above written.
Address of Assignor: ASSIGNOR:
485 Clyde Avenue CONSILIUM, INC.
Mountain View, CA 94043
By:
Printed Name:
Title:
Address of Assignee: ASSIGNEE:
3 Palo Alto Square, Suite 150 VENTURE BANKING GROUP, A
DIVISION OF
Palo Alto, California 94306 CUPERTINO NATIONAL BANK
By:
Printed Name:
Title:
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM THE ACCOMPANYING CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> OCT-31-1998
<PERIOD-START> NOV-01-1997
<PERIOD-END> JUL-31-1998
<CASH> 6,665
<SECURITIES> 0
<RECEIVABLES> 9,299
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 16,572
<PP&E> 2,630
<DEPRECIATION> 0
<TOTAL-ASSETS> 23,673
<CURRENT-LIABILITIES> 12,883
<BONDS> 0
0
0
<COMMON> 8,333
<OTHER-SE> 0
<TOTAL-LIABILITY-AND-EQUITY> 23,673
<SALES> 24,204
<TOTAL-REVENUES> 24,204
<CGS> 9,058
<TOTAL-COSTS> 9,058
<OTHER-EXPENSES> 15,985
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 239
<INCOME-PRETAX> (362)
<INCOME-TAX> 175
<INCOME-CONTINUING> (537)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (537)
<EPS-PRIMARY> ($0.16)
<EPS-DILUTED> ($0.16)
</TABLE>
